data_2lo4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lo4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.15 0.5 . . . . 3.42 110.969 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.511 ' O ' ' CB ' ' A' ' 37' ' ' PRO . 62.9 t-80 -158.3 149.22 20.67 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.543 -0.753 . . . . 4.5 109.994 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -136.97 137.04 39.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.917 -0.772 . . . . 1.86 108.917 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -65.59 115.39 21.81 Favored Pre-proline 0 C--O 1.214 -0.795 0 N-CA-C 107.246 -1.39 . . . . 1.58 107.246 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.71 -41.63 14.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 120.533 1.226 . . . . 1.81 112.713 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HZ3' ' CB ' ' A' ' 31' ' ' LYS . 10.0 mtpm? -67.19 -44.52 79.45 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.783 0.66 . . . . 4.77 112.783 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 32.11 1.17 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.195 0.522 . . . . 1.79 111.298 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -76.22 120.39 5.86 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 109.903 -1.279 . . . . 0.99 109.903 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 10.7 mt-10 153.49 -37.96 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.663 -1.606 . . . . 3.82 106.663 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.93 -31.39 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 113.144 -1.843 . . . . 4.79 108.249 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -172.26 72.12 0.45 Allowed Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 117.945 -1.502 . . . . 4.32 111.814 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' CB ' ' O ' ' A' ' 27' ' ' HIS . 87.1 Cg_endo -88.29 67.28 3.21 Favored 'Trans proline' 0 C--N 1.291 -2.49 0 C-N-CA 122.008 1.805 . . . . 4.39 112.381 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 4.6 p-10 -88.02 -77.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.513 0.931 . . . . 3.07 113.513 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.477 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 41.5 mt -156.05 -77.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 122.404 1.097 . . . . 3.09 111.32 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -88.01 -34.43 18.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 112.962 -1.926 . . . . 2.28 111.965 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -61.15 -40.42 93.77 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.539 -0.911 . . . . 2.68 108.539 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.61 -42.1 82.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 2.52 109.758 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -57.77 -29.47 64.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.471 -0.892 . . . . 3.27 109.171 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.48 -38.82 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.234 0.54 . . . . 2.01 109.555 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.512 ' CE1' ' SG ' ' A' ' 49' ' ' CYS . 2.7 t60 -63.27 -48.73 76.94 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.677 -0.692 . . . . 2.27 111.605 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 49' ' ' CYS . 1.6 p -61.21 -32.81 53.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.269 -0.423 . . . . 2.2 110.655 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.9 ttp -61.85 -34.36 75.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.201 -0.454 . . . . 3.0 110.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 66.3 t0 -90.9 -23.74 20.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.443 -0.577 . . . . 2.3 109.443 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.512 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 0.8 OUTLIER -91.95 163.24 14.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.507 -0.923 . . . . 0.7 108.507 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.541 ' N ' ' CD1' ' A' ' 50' ' ' ILE . 1.9 mp -103.84 86.4 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.387 -0.597 . . . . 3.0 109.387 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 118.319 -0.848 . . . . 2.66 110.089 -179.52 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.403 ' CD1' ' OD1' ' A' ' 38' ' ' ASP . 44.2 mm . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 3.42 110.845 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -147.98 127.63 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.638 -0.71 . . . . 4.5 109.853 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.88 156.84 39.01 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.554 -0.748 . . . . 1.86 109.245 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.565 ' H ' HD13 ' A' ' 36' ' ' LEU . 24.6 m -72.77 155.76 90.5 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 108.949 -0.76 . . . . 1.58 108.949 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.7 -61.27 0.55 Allowed 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 119.857 0.985 . . . . 1.81 111.995 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -99.94 -18.95 16.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.207 0.447 . . . . 4.77 112.207 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -100.5 -10.75 20.75 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.739 0.304 . . . . 1.79 110.488 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.36 94.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.428 -0.891 . . . . 0.99 111.242 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -163.63 -45.5 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.921 -0.77 . . . . 3.82 108.921 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -103.56 3.6 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.298 -0.865 . . . . 4.79 110.36 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 29' ' ' CYS . 16.0 mt -79.89 149.27 70.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 118.63 -1.228 . . . . 4.32 112.126 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 91.0 Cg_endo -76.33 -99.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.019 1.813 . . . . 4.39 112.86 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 72.7 m-20 -143.38 -54.7 0.39 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.55 1.315 . . . . 3.07 114.55 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.9 mm -143.01 -24.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.191 0.441 . . . . 3.09 112.191 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.78 -83.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.233 -0.439 . . . . 2.28 110.632 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -73.74 -4.35 33.97 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.348 -0.982 . . . . 2.68 108.348 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 42' ' ' LEU . 2.3 tm? -76.08 -55.37 5.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.299 -0.864 . . . . 2.52 110.146 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -68.63 -39.12 80.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.444 -0.798 . . . . 3.27 111.873 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.84 -51.07 48.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.499 0.666 . . . . 2.01 112.014 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.619 ' ND1' ' N ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -69.81 -20.21 63.46 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.794 0.807 . . . . 2.27 110.636 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.619 ' N ' ' ND1' ' A' ' 45' ' ' HIS . 1.2 t -57.91 -43.88 85.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.035 -1.469 . . . . 2.2 107.035 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.3 mmm -59.74 -25.78 65.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.554 -1.276 . . . . 3.0 107.554 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.38 -24.75 20.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.784 -0.644 . . . . 2.3 111.536 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' HIS . 53.2 m -91.55 -176.0 4.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.014 -1.106 . . . . 0.7 108.014 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -108.73 80.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 3.0 110.206 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.918 -1.039 . . . . 2.66 110.456 179.654 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.7 pt . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.984 0.421 . . . . 3.42 110.982 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -149.26 140.69 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 4.5 110.315 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 p -134.11 151.13 51.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.668 -0.697 . . . . 1.86 109.357 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.647 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -67.87 115.89 32.61 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 108.081 -1.081 . . . . 1.58 108.081 177.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -47.26 -40.8 28.06 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 CA-C-N 120.684 1.28 . . . . 1.81 112.815 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.74 -49.18 60.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.639 0.978 . . . . 4.77 113.639 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.61 29.89 3.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.861 0.362 . . . . 1.79 110.535 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -99.26 133.78 11.43 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.314 -0.714 . . . . 0.99 111.314 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -168.79 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.518 -0.473 . . . . 3.82 110.406 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 m -124.66 9.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.815 -0.629 . . . . 4.79 109.86 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.7 mt -77.88 146.79 72.81 Favored Pre-proline 0 C--O 1.225 -0.213 0 C-N-CA 119.261 -0.976 . . . . 4.32 110.668 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.8 Cg_exo -36.95 -128.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.803 3.002 . . . . 4.39 114.52 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 93.1 m-20 -142.01 -39.71 0.37 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.268 0.47 . . . . 3.07 112.268 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.489 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 11.2 pt -146.68 -20.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 3.09 111.877 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -71.03 -74.84 0.14 Allowed 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 119.51 -0.876 . . . . 2.28 108.715 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 -14.09 59.65 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.027 -0.669 . . . . 2.68 109.416 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.86 -42.92 69.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.228 0.537 . . . . 2.52 110.072 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 13.5 mm-40 -63.88 -33.6 76.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.625 -0.83 . . . . 3.27 108.918 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.5 mm -77.25 -40.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.116 -0.634 . . . . 2.01 110.74 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.474 ' ND1' ' CD1' ' A' ' 36' ' ' LEU . 15.3 t-160 -64.6 -46.98 80.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 2.27 111.041 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 49' ' ' CYS . 17.0 m -62.52 -29.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.736 -0.386 . . . . 2.2 110.865 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 67.5 mtp -61.76 -35.76 79.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.707 -0.397 . . . . 3.0 110.05 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 49' ' ' CYS . 3.3 p30 -94.08 -32.65 13.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.853 -0.339 . . . . 2.3 110.458 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 1.3 m -96.64 -174.73 3.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.946 -0.761 . . . . 0.7 108.946 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 50' ' ' ILE . 22.0 mm -103.13 101.86 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.892 -0.41 . . . . 3.0 109.892 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 51' ' ' ILE . 86.0 mt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.323 -0.846 . . . . 2.66 109.745 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.078 0.466 . . . . 3.42 110.74 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -149.68 140.15 22.43 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.038 -0.528 . . . . 4.5 110.324 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -128.9 160.04 33.91 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.11 -0.496 . . . . 1.86 110.113 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' H ' HD21 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -67.49 166.5 21.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.442 -0.345 . . . . 1.58 110.106 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.47 -50.98 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.358 1.372 . . . . 1.81 111.267 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -109.52 -53.95 2.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.978 -1.01 . . . . 4.77 111.295 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 3.53 5.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.407 -0.361 . . . . 1.79 110.607 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.05 110.1 2.99 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.63 -0.795 . . . . 0.99 112.07 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -173.11 -49.8 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.193 -1.04 . . . . 3.82 108.193 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 9.54 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.213 -0.903 . . . . 4.79 109.965 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.2 mp -75.9 131.49 76.15 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 119.079 -1.048 . . . . 4.32 110.883 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 36' ' ' LEU . 39.7 Cg_exo -42.56 -120.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.156 2.571 . . . . 4.39 113.748 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 99.7 m-20 -141.57 -47.88 0.38 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.138 0.494 . . . . 3.07 111.146 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 pt -144.31 -17.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.474 -0.785 . . . . 3.09 112.063 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.74 -81.37 0.06 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.67 -0.812 . . . . 2.28 109.279 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -79.71 -5.72 55.78 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.805 -0.758 . . . . 2.68 109.119 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.463 ' CD1' ' C ' ' A' ' 42' ' ' LEU . 2.9 tm? -73.92 -52.57 12.47 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.362 -0.535 . . . . 2.52 109.95 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -66.09 -31.69 72.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.822 -0.626 . . . . 3.27 110.583 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.12 -49.06 40.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.593 0.711 . . . . 2.01 110.584 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 49' ' ' CYS . 1.2 t60 -67.26 -44.6 78.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.539 -0.755 . . . . 2.27 111.818 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.16 -30.65 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.468 -0.493 . . . . 2.2 110.507 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.0 ttp -61.8 -33.85 74.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.49 -0.559 . . . . 3.0 109.49 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 67.7 t0 -89.47 -28.12 19.9 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.303 -0.628 . . . . 2.3 109.303 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 0.8 OUTLIER -90.89 -177.97 5.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.03 -0.729 . . . . 0.7 109.03 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.9 tt -106.52 110.63 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.391 0.615 . . . . 3.0 109.805 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.056 -0.974 . . . . 2.66 110.869 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 120.892 0.377 . . . . 3.42 110.739 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -151.54 142.24 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 4.5 109.871 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 167.2 20.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.114 -0.494 . . . . 1.86 109.97 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.613 ' SG ' ' CD1' ' A' ' 36' ' ' LEU . 90.5 m -72.23 159.77 84.51 Favored Pre-proline 0 N--CA 1.473 0.697 0 N-CA-C 108.33 -0.989 . . . . 1.58 108.33 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.19 -49.14 16.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.895 1.355 . . . . 1.81 112.738 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 33' ' ' GLY . 61.8 tttm -113.25 -51.86 2.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.901 0.382 . . . . 4.77 110.129 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -62.94 -5.89 3.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.019 -0.537 . . . . 1.79 109.922 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' LYS . . . -71.72 102.23 1.1 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.516 -0.849 . . . . 0.99 111.421 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.41 -50.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.637 -0.825 . . . . 3.82 110.564 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.83 12.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.468 -0.787 . . . . 4.79 109.898 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.613 ' CD1' ' SG ' ' A' ' 29' ' ' CYS . 10.4 mt -73.67 150.84 88.96 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 118.687 -1.205 . . . . 4.32 111.381 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' A' ' 36' ' ' LEU . 77.5 Cg_exo -44.45 -126.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.042 2.494 . . . . 4.39 113.435 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 98.1 m-20 -139.87 -59.69 0.55 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.817 -0.552 . . . . 3.07 112.26 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 69.3 mt -145.66 -35.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.092 0.472 . . . . 3.09 112.034 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -66.28 -81.94 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.884 -0.726 . . . . 2.28 109.689 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -10.74 60.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.901 -0.591 . . . . 2.68 109.483 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 42' ' ' LEU . 2.8 tm? -73.43 -48.74 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.52 -0.472 . . . . 2.52 110.132 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 40.4 mm-40 -58.75 -39.04 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.54 -0.755 . . . . 3.27 109.065 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -71.32 -40.03 72.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.666 0.746 . . . . 2.01 109.858 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.412 ' CE1' ' SG ' ' A' ' 49' ' ' CYS . 1.3 t60 -61.8 -44.75 96.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.732 -0.667 . . . . 2.27 112.108 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.37 -33.84 39.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.411 -0.589 . . . . 2.2 109.411 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 69.0 mtt -63.19 -28.75 70.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.839 -0.619 . . . . 3.0 109.602 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -87.27 -25.23 24.05 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.505 -0.478 . . . . 2.3 110.186 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 1.0 OUTLIER -93.08 -176.04 4.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.155 -0.683 . . . . 0.7 109.155 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 tt -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.575 0.703 . . . . 3.0 109.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 118.095 -0.955 . . . . 2.66 110.192 179.365 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 120.893 0.378 . . . . 3.42 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -141.86 142.15 33.1 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.123 -0.49 . . . . 4.5 109.789 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.35 158.32 44.71 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.086 -0.709 . . . . 1.86 109.086 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.408 ' N ' ' HA3' ' A' ' 33' ' ' GLY . 12.3 m -68.29 155.06 93.22 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 108.648 -0.871 . . . . 1.58 108.648 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -42.31 -62.62 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 CA-C-N 120.494 1.212 . . . . 1.81 112.543 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -102.27 -46.98 4.65 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.495 -0.32 . . . . 4.77 111.071 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.54 66.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.891 0.377 . . . . 1.79 110.06 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 29' ' ' CYS . . . -68.19 104.1 1.13 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.317 -0.944 . . . . 0.99 111.078 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' H ' HD21 ' A' ' 36' ' ' LEU . 81.6 mt-10 -148.26 -46.33 0.16 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.658 0.742 . . . . 3.82 110.293 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.37 12.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.481 -1.236 . . . . 4.79 109.552 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.612 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.6 mm? -74.97 152.12 86.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 118.781 -1.167 . . . . 4.32 110.365 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.5 Cg_exo -37.98 -137.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.998 3.132 . . . . 4.39 115.093 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 90.8 m-20 -139.29 -57.38 0.59 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.684 0.624 . . . . 3.07 112.684 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.1 pt -145.04 -34.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.269 0.47 . . . . 3.09 112.269 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.39 -75.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.527 0.68 . . . . 2.28 110.116 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.455 ' OG1' ' CG ' ' A' ' 37' ' ' PRO . 2.9 p -77.64 -7.13 55.96 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.922 -0.77 . . . . 2.68 108.922 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.77 -53.33 8.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.137 0.494 . . . . 2.52 111.04 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.08 -33.81 69.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.748 -0.834 . . . . 3.27 108.748 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mm -72.88 -42.22 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 119.708 -0.797 . . . . 2.01 109.585 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.408 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 3.7 t60 -65.06 -45.2 86.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.545 -0.752 . . . . 2.27 112.435 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -31.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.427 -0.509 . . . . 2.2 109.742 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 53.5 ttp -62.64 -31.72 72.63 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.762 -0.654 . . . . 3.0 109.406 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -88.36 -25.05 22.93 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.182 -0.463 . . . . 2.3 110.525 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.41 -176.49 4.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.553 -0.906 . . . . 0.7 108.553 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -107.38 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.479 . . . . 3.0 110.081 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 118.013 -0.994 . . . . 2.66 110.574 -179.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.497 ' O ' ' CG ' ' A' ' 27' ' ' HIS . 2.1 pp . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 121.166 0.508 . . . . 3.42 110.608 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 78.8 m80 -158.77 139.95 13.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 4.5 110.223 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 34' ' ' GLU . 5.0 p -116.67 155.11 29.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.746 -0.465 . . . . 1.86 109.746 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -69.16 133.79 89.58 Favored Pre-proline 0 C--O 1.214 -0.781 0 N-CA-C 106.697 -1.594 . . . . 1.58 106.697 177.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -35.6 23.85 Favored 'Trans proline' 0 C--N 1.298 -2.122 0 CA-C-N 121.02 1.4 . . . . 1.81 113.388 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -63.48 -40.87 98.24 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.14 0.422 . . . . 4.77 112.14 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 -15.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.712 0.291 . . . . 1.79 111.471 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -91.43 150.81 20.61 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 110.157 -1.177 . . . . 0.99 110.157 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' ' OG ' ' A' ' 28' ' ' SER . 82.8 mt-10 -155.49 -46.46 0.08 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.562 0.696 . . . . 3.82 110.381 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.03 9.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.675 -1.148 . . . . 4.79 110.015 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 mt -108.27 84.06 2.13 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 119.887 -0.725 . . . . 4.32 112.405 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.35 128.51 8.07 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.282 1.988 . . . . 4.39 111.747 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 40' ' ' ASP . 6.0 m-20 -142.61 35.1 1.44 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 112.933 0.716 . . . . 3.07 112.933 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 38' ' ' ASP . 9.0 tp -9.4 -37.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 124.676 1.235 . . . . 3.09 113.548 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.817 ' N ' ' O ' ' A' ' 38' ' ' ASP . 64.5 t0 -76.73 -61.45 1.96 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.496 -1.298 . . . . 2.28 107.496 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.619 ' N ' ' O ' ' A' ' 38' ' ' ASP . 4.8 m -78.41 -23.18 46.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.897 -0.592 . . . . 2.68 110.266 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.401 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 8.2 tp -71.16 -50.51 32.54 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 120.944 -0.302 . . . . 2.52 110.819 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.06 -24.88 64.93 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.92 -0.77 . . . . 3.27 108.92 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.05 -38.23 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.628 -0.714 . . . . 2.01 109.188 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.506 ' CE1' ' SG ' ' A' ' 49' ' ' CYS . 2.4 t60 -65.58 -47.42 75.83 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.913 -0.585 . . . . 2.27 111.007 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' CYS . 8.5 p -62.04 -31.51 51.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.418 . . . . 2.2 110.543 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.04 -34.16 74.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.761 -0.459 . . . . 3.0 109.761 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.83 -29.38 16.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 2.3 110.169 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.506 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 1.4 m -92.72 -179.67 5.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.176 -1.046 . . . . 0.7 108.176 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.413 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 47.8 mm -108.33 101.2 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.948 0.404 . . . . 3.0 110.422 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.413 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 20.3 tt . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.992 -1.004 . . . . 2.66 110.622 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 109.696 -0.483 . . . . 3.42 109.696 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -142.64 146.08 34.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.446 -0.576 . . . . 4.5 109.446 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.474 ' HA ' HD22 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -126.24 153.88 44.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.477 -0.328 . . . . 1.86 110.278 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -89.87 109.01 29.48 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 120.142 -0.623 . . . . 1.58 109.382 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' C ' ' O ' ' A' ' 29' ' ' CYS . 54.0 Cg_exo -37.02 -29.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 CA-C-N 121.076 1.42 . . . . 1.81 112.265 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' CYS . 52.7 tptt -65.24 -45.21 85.51 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.142 -0.481 . . . . 4.77 111.394 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.5 OUTLIER -149.85 14.37 0.83 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.833 -0.347 . . . . 1.79 111.796 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -59.47 111.91 3.84 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.889 -0.596 . . . . 0.99 111.927 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.588 ' H ' HD11 ' A' ' 36' ' ' LEU . 84.1 mt-10 -155.67 -52.29 0.09 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.66 0.743 . . . . 3.82 110.991 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.418 ' H ' HD11 ' A' ' 36' ' ' LEU . 1.4 m -131.21 11.37 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.599 -1.182 . . . . 4.79 111.16 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.736 ' CD2' ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.06 157.97 82.7 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 119.118 -1.033 . . . . 4.32 110.917 -178.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -22.97 -134.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 125.191 3.927 . . . . 4.39 115.332 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 85.4 m-20 -143.31 -59.19 0.42 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.19 0.811 . . . . 3.07 113.19 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -144.32 -41.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.226 0.454 . . . . 3.09 112.226 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.71 -74.26 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.263 -0.575 . . . . 2.28 110.463 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.9 m -69.39 -17.49 63.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.161 -0.681 . . . . 2.68 109.161 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -49.48 58.45 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.783 -0.644 . . . . 2.52 110.024 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -54.98 -33.16 62.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.335 -0.987 . . . . 3.27 108.335 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.0 -31.28 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.086 -0.645 . . . . 2.01 109.713 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -66.51 -47.2 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 2.27 111.508 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -59.37 -33.53 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.905 -0.718 . . . . 2.2 109.876 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -31.25 71.49 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.863 -0.608 . . . . 3.0 109.746 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.04 -23.83 21.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.715 0.293 . . . . 2.3 110.223 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -178.67 5.14 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.035 -0.728 . . . . 0.7 109.035 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -110.57 92.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.032 -0.359 . . . . 3.0 110.032 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.971 -1.014 . . . . 2.66 110.71 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.0 tt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.928 0.394 . . . . 3.42 111.714 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.538 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 p-80 -77.22 86.76 3.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.735 -0.666 . . . . 4.5 112.096 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.444 ' H ' HD21 ' A' ' 42' ' ' LEU . 13.2 p -156.79 162.31 39.74 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 121.721 0.772 . . . . 1.86 111.802 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -153.09 115.95 2.77 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 106.297 -1.742 . . . . 1.58 106.297 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -47.08 -41.27 26.72 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 121.448 1.553 . . . . 1.81 112.534 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -67.3 -42.51 83.61 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.094 0.776 . . . . 4.77 113.094 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.83 33.26 2.2 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 1.79 110.203 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -74.94 100.52 1.23 Allowed Glycine 0 C--O 1.23 -0.123 0 CA-C-N 115.714 -0.675 . . . . 0.99 111.906 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -154.39 -53.66 0.1 Allowed 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.901 0.858 . . . . 3.82 109.287 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 9.31 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.972 -1.467 . . . . 4.79 109.833 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 mm? -79.19 118.55 73.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 119.587 -0.845 . . . . 4.32 111.066 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 36' ' ' LEU . 72.8 Cg_exo -47.16 -150.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.128 2.552 . . . . 4.39 112.992 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.891 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -143.25 -71.63 0.31 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.909 1.337 . . . . 3.07 112.995 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 38' ' ' ASP . 96.9 mt -27.81 -62.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.53 -1.214 . . . . 3.09 111.9 -178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.0 -27.51 22.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.95 -1.023 . . . . 2.28 109.081 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 45' ' ' HIS . 29.5 m -82.72 -66.31 0.91 Allowed 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 114.073 -1.421 . . . . 2.68 110.239 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.891 ' N ' ' O ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -50.53 -34.59 25.93 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.088 -1.045 . . . . 2.52 109.936 -178.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -65.52 -63.5 1.08 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.693 -0.803 . . . . 3.27 112.221 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 62.4 mt -86.19 -35.26 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.694 0.627 . . . . 2.01 112.694 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 41' ' ' THR . 2.0 t60 -58.6 -43.56 89.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.95 -0.568 . . . . 2.27 110.137 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 49' ' ' CYS . 21.0 m -63.62 -39.34 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 119.693 -0.803 . . . . 2.2 110.05 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -28.38 15.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 119.489 -0.884 . . . . 3.0 109.958 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 1.2 p-10 -104.39 -34.5 8.26 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.933 -0.307 . . . . 2.3 111.376 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.498 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 42.6 m -94.85 -176.18 3.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.741 -0.837 . . . . 0.7 108.741 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.476 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 8.8 tp -100.41 87.08 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.299 0.571 . . . . 3.0 110.018 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 51' ' ' ILE . 14.0 mm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.168 -0.92 . . . . 2.66 110.034 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.533 ' O ' ' CG ' ' A' ' 27' ' ' HIS . 2.2 pp . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 108.792 -0.818 . . . . 3.42 108.792 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 99.2 m-70 -158.69 130.72 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 4.5 110.477 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.671 ' HG ' ' N ' ' A' ' 36' ' ' LEU . 2.4 m -95.34 160.81 14.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.434 -0.58 . . . . 1.86 109.434 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.468 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -66.49 175.54 1.31 Allowed Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 108.836 -0.801 . . . . 1.58 108.836 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' GLY . 26.1 Cg_endo -83.41 -73.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.127 1.218 . . . . 1.81 110.18 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.86 -44.9 65.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.845 -0.616 . . . . 4.77 110.879 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -46.56 52.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.192 0.52 . . . . 1.79 111.75 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 29' ' ' CYS . . . -114.66 -178.02 18.92 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 110.431 -1.067 . . . . 0.99 110.431 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -174.12 -47.63 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.946 -0.761 . . . . 3.82 108.946 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.2 10.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.739 -1.119 . . . . 4.79 109.647 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.671 ' N ' ' HG ' ' A' ' 28' ' ' SER . 45.3 mt -115.73 73.41 4.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 113.232 0.827 . . . . 4.32 113.232 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -87.53 117.17 1.19 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 123.146 2.564 . . . . 4.39 110.986 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -85.45 -77.91 0.28 Allowed 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 118.015 -1.474 . . . . 3.07 111.196 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.1 mt -154.45 -87.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.952 1.358 . . . . 3.09 110.309 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.86 -24.77 13.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.261 -1.791 . . . . 2.28 111.175 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -65.41 -44.01 88.77 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.734 -0.786 . . . . 2.68 109.071 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.48 -41.14 61.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.858 -0.61 . . . . 2.52 111.029 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.46 -41.05 89.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.508 -0.877 . . . . 3.27 110.031 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.5 -42.2 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.235 0.541 . . . . 2.01 110.572 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.412 ' CE1' ' SG ' ' A' ' 49' ' ' CYS . 1.4 t60 -60.67 -46.42 90.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 2.27 111.55 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -32.82 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.319 -0.552 . . . . 2.2 110.987 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.15 -35.66 77.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.1 -0.5 . . . . 3.0 109.874 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -92.73 -10.89 35.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.886 -0.412 . . . . 2.3 109.886 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -95.11 -178.84 4.61 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.65 -0.871 . . . . 0.7 108.65 178.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.414 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -109.78 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.911 0.386 . . . . 3.0 110.503 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.414 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 96.0 mt . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.088 -0.958 . . . . 2.66 111.449 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.601 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 110.1 -0.333 . . . . 5.27 110.1 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 24' ' ' ILE . 83.0 Cg_endo -88.49 -177.32 1.73 Allowed 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.442 2.095 . . . . 4.08 111.941 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 pt -124.83 160.26 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.15 0.5 . . . . 3.42 110.969 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.511 ' O ' ' CB ' ' A' ' 37' ' ' PRO . 62.9 t-80 -158.3 149.22 20.67 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.543 -0.753 . . . . 4.5 109.994 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -136.97 137.04 39.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.917 -0.772 . . . . 1.86 108.917 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -65.59 115.39 21.81 Favored Pre-proline 0 C--O 1.214 -0.795 0 N-CA-C 107.246 -1.39 . . . . 1.58 107.246 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.71 -41.63 14.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 120.533 1.226 . . . . 1.81 112.713 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HZ3' ' CB ' ' A' ' 31' ' ' LYS . 10.0 mtpm? -67.19 -44.52 79.45 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.783 0.66 . . . . 4.77 112.783 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 32.11 1.17 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.195 0.522 . . . . 1.79 111.298 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -76.22 120.39 5.86 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 109.903 -1.279 . . . . 0.99 109.903 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 10.7 mt-10 153.49 -37.96 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.663 -1.606 . . . . 3.82 106.663 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.93 -31.39 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 113.144 -1.843 . . . . 4.79 108.249 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -172.26 72.12 0.45 Allowed Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 117.945 -1.502 . . . . 4.32 111.814 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' CB ' ' O ' ' A' ' 27' ' ' HIS . 87.1 Cg_endo -88.29 67.28 3.21 Favored 'Trans proline' 0 C--N 1.291 -2.49 0 C-N-CA 122.008 1.805 . . . . 4.39 112.381 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 4.6 p-10 -88.02 -77.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.513 0.931 . . . . 3.07 113.513 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.477 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 41.5 mt -156.05 -77.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 122.404 1.097 . . . . 3.09 111.32 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -88.01 -34.43 18.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 112.962 -1.926 . . . . 2.28 111.965 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -61.15 -40.42 93.77 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.539 -0.911 . . . . 2.68 108.539 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.61 -42.1 82.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 2.52 109.758 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -57.77 -29.47 64.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.471 -0.892 . . . . 3.27 109.171 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.48 -38.82 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.234 0.54 . . . . 2.01 109.555 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -63.27 -48.73 76.94 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.677 -0.692 . . . . 2.27 111.605 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 49' ' ' CYS . 1.6 p -61.21 -32.81 53.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.269 -0.423 . . . . 2.2 110.655 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.9 ttp -61.85 -34.36 75.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.201 -0.454 . . . . 3.0 110.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 66.3 t0 -90.9 -23.74 20.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.443 -0.577 . . . . 2.3 109.443 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -91.95 163.24 14.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.507 -0.923 . . . . 0.7 108.507 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.541 ' N ' ' CD1' ' A' ' 50' ' ' ILE . 1.9 mp -103.84 86.4 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.387 -0.597 . . . . 3.0 109.387 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 118.319 -0.848 . . . . 2.66 110.089 -179.52 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 108.412 -0.958 . . . . 5.27 108.412 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.84 145.93 97.0 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.527 1.485 . . . . 4.08 111.64 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.403 ' CD1' ' OD1' ' A' ' 38' ' ' ASP . 44.2 mm -112.75 129.85 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 3.42 110.845 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -147.98 127.63 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.638 -0.71 . . . . 4.5 109.853 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.88 156.84 39.01 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.554 -0.748 . . . . 1.86 109.245 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.565 ' H ' HD13 ' A' ' 36' ' ' LEU . 24.6 m -72.77 155.76 90.5 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 108.949 -0.76 . . . . 1.58 108.949 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.7 -61.27 0.55 Allowed 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 119.857 0.985 . . . . 1.81 111.995 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -99.94 -18.95 16.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.207 0.447 . . . . 4.77 112.207 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -100.5 -10.75 20.75 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.739 0.304 . . . . 1.79 110.488 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.36 94.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.428 -0.891 . . . . 0.99 111.242 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -163.63 -45.5 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.921 -0.77 . . . . 3.82 108.921 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -103.56 3.6 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.298 -0.865 . . . . 4.79 110.36 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 29' ' ' CYS . 16.0 mt -79.89 149.27 70.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 118.63 -1.228 . . . . 4.32 112.126 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 91.0 Cg_endo -76.33 -99.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.019 1.813 . . . . 4.39 112.86 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 72.7 m-20 -143.38 -54.7 0.39 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.55 1.315 . . . . 3.07 114.55 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.9 mm -143.01 -24.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.191 0.441 . . . . 3.09 112.191 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.78 -83.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.233 -0.439 . . . . 2.28 110.632 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -73.74 -4.35 33.97 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.348 -0.982 . . . . 2.68 108.348 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 42' ' ' LEU . 2.3 tm? -76.08 -55.37 5.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.299 -0.864 . . . . 2.52 110.146 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -68.63 -39.12 80.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.444 -0.798 . . . . 3.27 111.873 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.84 -51.07 48.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.499 0.666 . . . . 2.01 112.014 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.619 ' ND1' ' N ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -69.81 -20.21 63.46 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.794 0.807 . . . . 2.27 110.636 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.619 ' N ' ' ND1' ' A' ' 45' ' ' HIS . 1.2 t -57.91 -43.88 85.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.035 -1.469 . . . . 2.2 107.035 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.3 mmm -59.74 -25.78 65.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.554 -1.276 . . . . 3.0 107.554 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.38 -24.75 20.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.784 -0.644 . . . . 2.3 111.536 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' HIS . 53.2 m -91.55 -176.0 4.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.014 -1.106 . . . . 0.7 108.014 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -108.73 80.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 3.0 110.206 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.918 -1.039 . . . . 2.66 110.456 179.654 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.098 -0.704 . . . . 5.27 109.098 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.04 156.2 47.43 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.738 2.292 . . . . 4.08 112.196 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.7 pt -77.4 166.92 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 3.42 110.982 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -149.26 140.69 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 4.5 110.315 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 p -134.11 151.13 51.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.668 -0.697 . . . . 1.86 109.357 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.647 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -67.87 115.89 32.61 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 108.081 -1.081 . . . . 1.58 108.081 177.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -47.26 -40.8 28.06 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 CA-C-N 120.684 1.28 . . . . 1.81 112.815 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.74 -49.18 60.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.639 0.978 . . . . 4.77 113.639 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.61 29.89 3.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.861 0.362 . . . . 1.79 110.535 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -99.26 133.78 11.43 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.314 -0.714 . . . . 0.99 111.314 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -168.79 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.518 -0.473 . . . . 3.82 110.406 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 m -124.66 9.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.815 -0.629 . . . . 4.79 109.86 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.7 mt -77.88 146.79 72.81 Favored Pre-proline 0 C--O 1.225 -0.213 0 C-N-CA 119.261 -0.976 . . . . 4.32 110.668 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.8 Cg_exo -36.95 -128.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.803 3.002 . . . . 4.39 114.52 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 93.1 m-20 -142.01 -39.71 0.37 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.268 0.47 . . . . 3.07 112.268 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.489 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 11.2 pt -146.68 -20.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 3.09 111.877 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -71.03 -74.84 0.14 Allowed 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 119.51 -0.876 . . . . 2.28 108.715 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 -14.09 59.65 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.027 -0.669 . . . . 2.68 109.416 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.86 -42.92 69.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.228 0.537 . . . . 2.52 110.072 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 13.5 mm-40 -63.88 -33.6 76.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.625 -0.83 . . . . 3.27 108.918 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.5 mm -77.25 -40.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.116 -0.634 . . . . 2.01 110.74 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.474 ' ND1' ' CD1' ' A' ' 36' ' ' LEU . 15.3 t-160 -64.6 -46.98 80.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 2.27 111.041 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 49' ' ' CYS . 17.0 m -62.52 -29.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.736 -0.386 . . . . 2.2 110.865 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 67.5 mtp -61.76 -35.76 79.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.707 -0.397 . . . . 3.0 110.05 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 49' ' ' CYS . 3.3 p30 -94.08 -32.65 13.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.853 -0.339 . . . . 2.3 110.458 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 1.3 m -96.64 -174.73 3.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.946 -0.761 . . . . 0.7 108.946 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 50' ' ' ILE . 22.0 mm -103.13 101.86 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.892 -0.41 . . . . 3.0 109.892 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 51' ' ' ILE . 86.0 mt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.323 -0.846 . . . . 2.66 109.745 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.5 mm . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.158 -0.682 . . . . 5.27 109.158 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.88 143.86 37.6 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.44 2.093 . . . . 4.08 111.862 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 tp -91.48 127.63 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 121.078 0.466 . . . . 3.42 110.74 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -149.68 140.15 22.43 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.038 -0.528 . . . . 4.5 110.324 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -128.9 160.04 33.91 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.11 -0.496 . . . . 1.86 110.113 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' H ' HD21 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -67.49 166.5 21.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.442 -0.345 . . . . 1.58 110.106 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.47 -50.98 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.358 1.372 . . . . 1.81 111.267 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -109.52 -53.95 2.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.978 -1.01 . . . . 4.77 111.295 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 3.53 5.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.407 -0.361 . . . . 1.79 110.607 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.05 110.1 2.99 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.63 -0.795 . . . . 0.99 112.07 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -173.11 -49.8 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.193 -1.04 . . . . 3.82 108.193 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 9.54 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.213 -0.903 . . . . 4.79 109.965 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.2 mp -75.9 131.49 76.15 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 119.079 -1.048 . . . . 4.32 110.883 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 36' ' ' LEU . 39.7 Cg_exo -42.56 -120.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.156 2.571 . . . . 4.39 113.748 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 99.7 m-20 -141.57 -47.88 0.38 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.138 0.494 . . . . 3.07 111.146 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 pt -144.31 -17.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.474 -0.785 . . . . 3.09 112.063 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.74 -81.37 0.06 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.67 -0.812 . . . . 2.28 109.279 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -79.71 -5.72 55.78 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.805 -0.758 . . . . 2.68 109.119 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.463 ' CD1' ' C ' ' A' ' 42' ' ' LEU . 2.9 tm? -73.92 -52.57 12.47 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.362 -0.535 . . . . 2.52 109.95 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -66.09 -31.69 72.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.822 -0.626 . . . . 3.27 110.583 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.12 -49.06 40.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.593 0.711 . . . . 2.01 110.584 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -67.26 -44.6 78.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.539 -0.755 . . . . 2.27 111.818 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.16 -30.65 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.468 -0.493 . . . . 2.2 110.507 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.0 ttp -61.8 -33.85 74.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.49 -0.559 . . . . 3.0 109.49 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 67.7 t0 -89.47 -28.12 19.9 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.303 -0.628 . . . . 2.3 109.303 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.89 -177.97 5.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.03 -0.729 . . . . 0.7 109.03 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.9 tt -106.52 110.63 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.391 0.615 . . . . 3.0 109.805 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.056 -0.974 . . . . 2.66 110.869 -179.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.564 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 mp . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 110.236 -0.283 . . . . 5.27 110.236 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 24' ' ' ILE . 91.3 Cg_endo -85.06 155.53 11.23 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.389 1.393 . . . . 4.08 112.308 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 pt -131.15 166.04 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.787 -0.642 . . . . 3.42 110.739 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -151.54 142.24 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 4.5 109.871 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 167.2 20.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.114 -0.494 . . . . 1.86 109.97 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.613 ' SG ' ' CD1' ' A' ' 36' ' ' LEU . 90.5 m -72.23 159.77 84.51 Favored Pre-proline 0 N--CA 1.473 0.697 0 N-CA-C 108.33 -0.989 . . . . 1.58 108.33 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.19 -49.14 16.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.895 1.355 . . . . 1.81 112.738 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 33' ' ' GLY . 61.8 tttm -113.25 -51.86 2.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.901 0.382 . . . . 4.77 110.129 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -62.94 -5.89 3.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.019 -0.537 . . . . 1.79 109.922 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' LYS . . . -71.72 102.23 1.1 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.516 -0.849 . . . . 0.99 111.421 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.41 -50.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.637 -0.825 . . . . 3.82 110.564 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.83 12.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.468 -0.787 . . . . 4.79 109.898 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.613 ' CD1' ' SG ' ' A' ' 29' ' ' CYS . 10.4 mt -73.67 150.84 88.96 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 118.687 -1.205 . . . . 4.32 111.381 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' A' ' 36' ' ' LEU . 77.5 Cg_exo -44.45 -126.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.042 2.494 . . . . 4.39 113.435 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 98.1 m-20 -139.87 -59.69 0.55 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.817 -0.552 . . . . 3.07 112.26 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 69.3 mt -145.66 -35.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.092 0.472 . . . . 3.09 112.034 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -66.28 -81.94 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.884 -0.726 . . . . 2.28 109.689 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -10.74 60.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.901 -0.591 . . . . 2.68 109.483 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 42' ' ' LEU . 2.8 tm? -73.43 -48.74 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.52 -0.472 . . . . 2.52 110.132 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 40.4 mm-40 -58.75 -39.04 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.54 -0.755 . . . . 3.27 109.065 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -71.32 -40.03 72.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.666 0.746 . . . . 2.01 109.858 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.404 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 1.3 t60 -61.8 -44.75 96.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.732 -0.667 . . . . 2.27 112.108 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.37 -33.84 39.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.411 -0.589 . . . . 2.2 109.411 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 69.0 mtt -63.19 -28.75 70.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.839 -0.619 . . . . 3.0 109.602 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -87.27 -25.23 24.05 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.505 -0.478 . . . . 2.3 110.186 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -93.08 -176.04 4.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.155 -0.683 . . . . 0.7 109.155 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 tt -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.575 0.703 . . . . 3.0 109.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 118.095 -0.955 . . . . 2.66 110.192 179.365 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 25' ' ' PRO . 9.1 tt . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 108.099 -1.075 . . . . 5.27 108.099 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 24' ' ' ILE . 17.4 Cg_exo -29.72 123.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.69 2.26 . . . . 4.08 113.952 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.0 tt -130.06 139.81 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.09 -0.959 . . . . 3.42 110.543 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -141.86 142.15 33.1 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.123 -0.49 . . . . 4.5 109.789 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.35 158.32 44.71 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.086 -0.709 . . . . 1.86 109.086 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.408 ' N ' ' HA3' ' A' ' 33' ' ' GLY . 12.3 m -68.29 155.06 93.22 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 108.648 -0.871 . . . . 1.58 108.648 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -42.31 -62.62 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 CA-C-N 120.494 1.212 . . . . 1.81 112.543 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -102.27 -46.98 4.65 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.495 -0.32 . . . . 4.77 111.071 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.54 66.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.891 0.377 . . . . 1.79 110.06 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 29' ' ' CYS . . . -68.19 104.1 1.13 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.317 -0.944 . . . . 0.99 111.078 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' H ' HD21 ' A' ' 36' ' ' LEU . 81.6 mt-10 -148.26 -46.33 0.16 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.658 0.742 . . . . 3.82 110.293 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.37 12.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.481 -1.236 . . . . 4.79 109.552 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.612 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.6 mm? -74.97 152.12 86.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 118.781 -1.167 . . . . 4.32 110.365 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.5 Cg_exo -37.98 -137.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.998 3.132 . . . . 4.39 115.093 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 90.8 m-20 -139.29 -57.38 0.59 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.684 0.624 . . . . 3.07 112.684 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.1 pt -145.04 -34.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.269 0.47 . . . . 3.09 112.269 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.39 -75.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.527 0.68 . . . . 2.28 110.116 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.455 ' OG1' ' CG ' ' A' ' 37' ' ' PRO . 2.9 p -77.64 -7.13 55.96 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.922 -0.77 . . . . 2.68 108.922 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.77 -53.33 8.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.137 0.494 . . . . 2.52 111.04 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.08 -33.81 69.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.748 -0.834 . . . . 3.27 108.748 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mm -72.88 -42.22 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 119.708 -0.797 . . . . 2.01 109.585 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.408 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 3.7 t60 -65.06 -45.2 86.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.545 -0.752 . . . . 2.27 112.435 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -31.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.427 -0.509 . . . . 2.2 109.742 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 53.5 ttp -62.64 -31.72 72.63 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.762 -0.654 . . . . 3.0 109.406 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -88.36 -25.05 22.93 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.182 -0.463 . . . . 2.3 110.525 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.41 -176.49 4.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.553 -0.906 . . . . 0.7 108.553 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -107.38 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.479 . . . . 3.0 110.081 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 118.013 -0.994 . . . . 2.66 110.574 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.647 -0.871 . . . . 5.27 108.647 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.25 151.72 66.42 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.36 2.04 . . . . 4.08 111.969 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.497 ' O ' ' CG ' ' A' ' 27' ' ' HIS . 2.1 pp -118.23 115.77 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.166 0.508 . . . . 3.42 110.608 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 78.8 m80 -158.77 139.95 13.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 4.5 110.223 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 34' ' ' GLU . 5.0 p -116.67 155.11 29.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.746 -0.465 . . . . 1.86 109.746 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -69.16 133.79 89.58 Favored Pre-proline 0 C--O 1.214 -0.781 0 N-CA-C 106.697 -1.594 . . . . 1.58 106.697 177.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -35.6 23.85 Favored 'Trans proline' 0 C--N 1.298 -2.122 0 CA-C-N 121.02 1.4 . . . . 1.81 113.388 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -63.48 -40.87 98.24 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.14 0.422 . . . . 4.77 112.14 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 -15.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.712 0.291 . . . . 1.79 111.471 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -91.43 150.81 20.61 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 110.157 -1.177 . . . . 0.99 110.157 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' ' OG ' ' A' ' 28' ' ' SER . 82.8 mt-10 -155.49 -46.46 0.08 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.562 0.696 . . . . 3.82 110.381 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.03 9.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.675 -1.148 . . . . 4.79 110.015 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 mt -108.27 84.06 2.13 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 119.887 -0.725 . . . . 4.32 112.405 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.35 128.51 8.07 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.282 1.988 . . . . 4.39 111.747 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 40' ' ' ASP . 6.0 m-20 -142.61 35.1 1.44 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 112.933 0.716 . . . . 3.07 112.933 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 38' ' ' ASP . 9.0 tp -9.4 -37.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 124.676 1.235 . . . . 3.09 113.548 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.817 ' N ' ' O ' ' A' ' 38' ' ' ASP . 64.5 t0 -76.73 -61.45 1.96 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.496 -1.298 . . . . 2.28 107.496 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.619 ' N ' ' O ' ' A' ' 38' ' ' ASP . 4.8 m -78.41 -23.18 46.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.897 -0.592 . . . . 2.68 110.266 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.401 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 8.2 tp -71.16 -50.51 32.54 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 120.944 -0.302 . . . . 2.52 110.819 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.06 -24.88 64.93 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.92 -0.77 . . . . 3.27 108.92 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.05 -38.23 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.628 -0.714 . . . . 2.01 109.188 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -65.58 -47.42 75.83 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.913 -0.585 . . . . 2.27 111.007 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' CYS . 8.5 p -62.04 -31.51 51.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.418 . . . . 2.2 110.543 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.04 -34.16 74.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.761 -0.459 . . . . 3.0 109.761 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.83 -29.38 16.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 2.3 110.169 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 46' ' ' VAL . 1.4 m -92.72 -179.67 5.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.176 -1.046 . . . . 0.7 108.176 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.413 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 47.8 mm -108.33 101.2 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.948 0.404 . . . . 3.0 110.422 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.413 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 20.3 tt . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.992 -1.004 . . . . 2.66 110.622 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 mm . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.577 -0.527 . . . . 5.27 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.34 125.08 16.04 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 121.669 1.579 . . . . 4.08 112.528 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.3 pt -140.88 163.2 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.696 -0.483 . . . . 3.42 109.696 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -142.64 146.08 34.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.446 -0.576 . . . . 4.5 109.446 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.474 ' HA ' HD22 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -126.24 153.88 44.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.477 -0.328 . . . . 1.86 110.278 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -89.87 109.01 29.48 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 120.142 -0.623 . . . . 1.58 109.382 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' C ' ' O ' ' A' ' 29' ' ' CYS . 54.0 Cg_exo -37.02 -29.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 CA-C-N 121.076 1.42 . . . . 1.81 112.265 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' CYS . 52.7 tptt -65.24 -45.21 85.51 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.142 -0.481 . . . . 4.77 111.394 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.5 OUTLIER -149.85 14.37 0.83 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.833 -0.347 . . . . 1.79 111.796 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -59.47 111.91 3.84 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.889 -0.596 . . . . 0.99 111.927 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.588 ' H ' HD11 ' A' ' 36' ' ' LEU . 84.1 mt-10 -155.67 -52.29 0.09 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.66 0.743 . . . . 3.82 110.991 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' H ' HD11 ' A' ' 36' ' ' LEU . 1.4 m -131.21 11.37 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.599 -1.182 . . . . 4.79 111.16 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.736 ' CD2' ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.06 157.97 82.7 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 119.118 -1.033 . . . . 4.32 110.917 -178.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -22.97 -134.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 125.191 3.927 . . . . 4.39 115.332 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 85.4 m-20 -143.31 -59.19 0.42 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.19 0.811 . . . . 3.07 113.19 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -144.32 -41.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.226 0.454 . . . . 3.09 112.226 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.71 -74.26 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.263 -0.575 . . . . 2.28 110.463 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.9 m -69.39 -17.49 63.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.161 -0.681 . . . . 2.68 109.161 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -49.48 58.45 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.783 -0.644 . . . . 2.52 110.024 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -54.98 -33.16 62.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.335 -0.987 . . . . 3.27 108.335 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.0 -31.28 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.086 -0.645 . . . . 2.01 109.713 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -66.51 -47.2 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 2.27 111.508 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -59.37 -33.53 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.905 -0.718 . . . . 2.2 109.876 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -31.25 71.49 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.863 -0.608 . . . . 3.0 109.746 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.04 -23.83 21.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.715 0.293 . . . . 2.3 110.223 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -178.67 5.14 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.035 -0.728 . . . . 0.7 109.035 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -110.57 92.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.032 -0.359 . . . . 3.0 110.032 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.971 -1.014 . . . . 2.66 110.71 -179.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.438 -0.578 . . . . 5.27 109.438 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.31 172.01 11.87 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.94 2.426 . . . . 4.08 111.433 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.0 tt -61.18 160.07 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.928 0.394 . . . . 3.42 111.714 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.538 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 p-80 -77.22 86.76 3.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.735 -0.666 . . . . 4.5 112.096 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.444 ' H ' HD21 ' A' ' 42' ' ' LEU . 13.2 p -156.79 162.31 39.74 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 121.721 0.772 . . . . 1.86 111.802 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -153.09 115.95 2.77 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 106.297 -1.742 . . . . 1.58 106.297 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -47.08 -41.27 26.72 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 121.448 1.553 . . . . 1.81 112.534 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -67.3 -42.51 83.61 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.094 0.776 . . . . 4.77 113.094 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.83 33.26 2.2 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 1.79 110.203 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -74.94 100.52 1.23 Allowed Glycine 0 C--O 1.23 -0.123 0 CA-C-N 115.714 -0.675 . . . . 0.99 111.906 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -154.39 -53.66 0.1 Allowed 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.901 0.858 . . . . 3.82 109.287 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 9.31 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.972 -1.467 . . . . 4.79 109.833 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 mm? -79.19 118.55 73.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 119.587 -0.845 . . . . 4.32 111.066 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 36' ' ' LEU . 72.8 Cg_exo -47.16 -150.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.128 2.552 . . . . 4.39 112.992 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.891 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -143.25 -71.63 0.31 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.909 1.337 . . . . 3.07 112.995 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 38' ' ' ASP . 96.9 mt -27.81 -62.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.53 -1.214 . . . . 3.09 111.9 -178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.0 -27.51 22.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.95 -1.023 . . . . 2.28 109.081 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 45' ' ' HIS . 29.5 m -82.72 -66.31 0.91 Allowed 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 114.073 -1.421 . . . . 2.68 110.239 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.891 ' N ' ' O ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -50.53 -34.59 25.93 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.088 -1.045 . . . . 2.52 109.936 -178.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -65.52 -63.5 1.08 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.693 -0.803 . . . . 3.27 112.221 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 62.4 mt -86.19 -35.26 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.694 0.627 . . . . 2.01 112.694 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 41' ' ' THR . 2.0 t60 -58.6 -43.56 89.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.95 -0.568 . . . . 2.27 110.137 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 49' ' ' CYS . 21.0 m -63.62 -39.34 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 119.693 -0.803 . . . . 2.2 110.05 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -28.38 15.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 119.489 -0.884 . . . . 3.0 109.958 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 1.2 p-10 -104.39 -34.5 8.26 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.933 -0.307 . . . . 2.3 111.376 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 46' ' ' VAL . 42.6 m -94.85 -176.18 3.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.741 -0.837 . . . . 0.7 108.741 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.476 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 8.8 tp -100.41 87.08 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.299 0.571 . . . . 3.0 110.018 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 51' ' ' ILE . 14.0 mm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.168 -0.92 . . . . 2.66 110.034 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.45 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 15.9 mt . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 108.42 -0.956 . . . . 5.27 108.42 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 24' ' ' ILE . 98.8 Cg_exo -34.45 140.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 122.57 2.18 . . . . 4.08 112.143 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.533 ' O ' ' CG ' ' A' ' 27' ' ' HIS . 2.2 pp -121.33 117.98 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.792 -0.818 . . . . 3.42 108.792 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 99.2 m-70 -158.69 130.72 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 4.5 110.477 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.671 ' HG ' ' N ' ' A' ' 36' ' ' LEU . 2.4 m -95.34 160.81 14.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.434 -0.58 . . . . 1.86 109.434 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.468 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -66.49 175.54 1.31 Allowed Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 108.836 -0.801 . . . . 1.58 108.836 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' GLY . 26.1 Cg_endo -83.41 -73.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.127 1.218 . . . . 1.81 110.18 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.86 -44.9 65.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.845 -0.616 . . . . 4.77 110.879 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -46.56 52.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.192 0.52 . . . . 1.79 111.75 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 29' ' ' CYS . . . -114.66 -178.02 18.92 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 110.431 -1.067 . . . . 0.99 110.431 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -174.12 -47.63 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.946 -0.761 . . . . 3.82 108.946 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.2 10.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.739 -1.119 . . . . 4.79 109.647 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.671 ' N ' ' HG ' ' A' ' 28' ' ' SER . 45.3 mt -115.73 73.41 4.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 113.232 0.827 . . . . 4.32 113.232 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -87.53 117.17 1.19 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 123.146 2.564 . . . . 4.39 110.986 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -85.45 -77.91 0.28 Allowed 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 118.015 -1.474 . . . . 3.07 111.196 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.1 mt -154.45 -87.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.952 1.358 . . . . 3.09 110.309 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.86 -24.77 13.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.261 -1.791 . . . . 2.28 111.175 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -65.41 -44.01 88.77 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.734 -0.786 . . . . 2.68 109.071 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.48 -41.14 61.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.858 -0.61 . . . . 2.52 111.029 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.46 -41.05 89.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.508 -0.877 . . . . 3.27 110.031 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.5 -42.2 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.235 0.541 . . . . 2.01 110.572 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.67 -46.42 90.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 2.27 111.55 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -32.82 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.319 -0.552 . . . . 2.2 110.987 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.15 -35.66 77.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.1 -0.5 . . . . 3.0 109.874 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -92.73 -10.89 35.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.886 -0.412 . . . . 2.3 109.886 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.11 -178.84 4.61 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.65 -0.871 . . . . 0.7 108.65 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.414 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -109.78 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.911 0.386 . . . . 3.0 110.503 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.414 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 96.0 mt . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.088 -0.958 . . . . 2.66 111.449 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.15 0.5 . . . . 2.9399999999999999 110.969 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.632 ' ND1' HD12 ' A' ' 42' ' ' LEU . 62.9 t-80 -158.3 149.22 20.67 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.543 -0.753 . . . . 3.7799999999999998 109.994 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -136.97 137.04 39.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.917 -0.772 . . . . 1.4299999999999999 108.917 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -65.59 115.39 21.81 Favored Pre-proline 0 C--O 1.214 -0.795 0 N-CA-C 107.246 -1.39 . . . . 0.92000000000000004 107.246 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.71 -41.63 14.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 120.533 1.226 . . . . 1.3700000000000001 112.713 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.19 -44.52 79.45 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.783 0.66 . . . . 4.29 112.783 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 32.11 1.17 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.195 0.522 . . . . 1.0 111.298 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -76.22 120.39 5.86 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 109.903 -1.279 . . . . 0.98999999999999999 109.903 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 10.7 mt-10 153.49 -37.96 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.663 -1.606 . . . . 3.8199999999999998 106.663 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.93 -31.39 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 113.144 -1.843 . . . . 4.4699999999999998 108.249 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -172.26 72.12 0.45 Allowed Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 117.945 -1.502 . . . . 3.7999999999999998 111.814 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' CB ' ' O ' ' A' ' 27' ' ' HIS . 87.1 Cg_endo -88.29 67.28 3.21 Favored 'Trans proline' 0 C--N 1.291 -2.49 0 C-N-CA 122.008 1.805 . . . . 3.6099999999999999 112.381 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 4.6 p-10 -88.02 -77.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.513 0.931 . . . . 3.0699999999999998 113.513 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.444 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 41.5 mt -156.05 -77.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 122.404 1.097 . . . . 2.6200000000000001 111.32 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -88.01 -34.43 18.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 112.962 -1.926 . . . . 2.2799999999999998 111.965 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -61.15 -40.42 93.77 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.539 -0.911 . . . . 2.1299999999999999 108.539 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -67.61 -42.1 82.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 1.9399999999999999 109.758 179.208 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -57.77 -29.47 64.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.471 -0.892 . . . . 2.7799999999999998 109.171 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.48 -38.82 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.234 0.54 . . . . 1.3100000000000001 109.555 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -63.27 -48.73 76.94 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.677 -0.692 . . . . 1.5600000000000001 111.605 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 49' ' ' CYS . 1.6 p -61.21 -32.81 53.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.269 -0.423 . . . . 1.54 110.655 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.9 ttp -61.85 -34.36 75.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.201 -0.454 . . . . 2.4500000000000002 110.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 66.3 t0 -90.9 -23.74 20.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.443 -0.577 . . . . 2.2999999999999998 109.443 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.527 ' C ' HD12 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -91.95 163.24 14.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.507 -0.923 . . . . 0.69999999999999996 108.507 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.753 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.9 mp -103.84 86.4 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.387 -0.597 . . . . 2.5099999999999998 109.387 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 118.319 -0.848 . . . . 2.29 110.089 -179.52 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.403 ' CD1' ' OD1' ' A' ' 38' ' ' ASP . 44.2 mm . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 2.9399999999999999 110.845 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -147.98 127.63 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.638 -0.71 . . . . 3.7799999999999998 109.853 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.88 156.84 39.01 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.554 -0.748 . . . . 1.4299999999999999 109.245 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.439 ' H ' HD12 ' A' ' 36' ' ' LEU . 24.6 m -72.77 155.76 90.5 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 108.949 -0.76 . . . . 0.92000000000000004 108.949 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.7 -61.27 0.55 Allowed 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 119.857 0.985 . . . . 1.3700000000000001 111.995 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -99.94 -18.95 16.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.207 0.447 . . . . 4.29 112.207 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -100.5 -10.75 20.75 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.739 0.304 . . . . 1.0 110.488 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.36 94.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.428 -0.891 . . . . 0.98999999999999999 111.242 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -163.63 -45.5 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.921 -0.77 . . . . 3.8199999999999998 108.921 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -103.56 3.6 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.298 -0.865 . . . . 4.4699999999999998 110.36 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.631 ' CD1' ' HE2' ' A' ' 45' ' ' HIS . 16.0 mt -79.89 149.27 70.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 118.63 -1.228 . . . . 3.7999999999999998 112.126 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 91.0 Cg_endo -76.33 -99.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.019 1.813 . . . . 3.6099999999999999 112.86 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.844 ' O ' HD13 ' A' ' 39' ' ' ILE . 72.7 m-20 -143.38 -54.7 0.39 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.55 1.315 . . . . 3.0699999999999998 114.55 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.844 HD13 ' O ' ' A' ' 38' ' ' ASP . 6.9 mm -143.01 -24.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.191 0.441 . . . . 2.6200000000000001 112.191 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.78 -83.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.233 -0.439 . . . . 2.2799999999999998 110.632 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -73.74 -4.35 33.97 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.348 -0.982 . . . . 2.1299999999999999 108.348 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.704 HD13 ' C ' ' A' ' 42' ' ' LEU . 2.3 tm? -76.08 -55.37 5.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.299 -0.864 . . . . 1.9399999999999999 110.146 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.453 ' N ' HD13 ' A' ' 42' ' ' LEU . 78.4 mt-30 -68.63 -39.12 80.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.444 -0.798 . . . . 2.7799999999999998 111.873 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.84 -51.07 48.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.499 0.666 . . . . 1.3100000000000001 112.014 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.631 ' HE2' ' CD1' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.81 -20.21 63.46 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.794 0.807 . . . . 1.5600000000000001 110.636 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.619 ' N ' ' ND1' ' A' ' 45' ' ' HIS . 1.2 t -57.91 -43.88 85.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.035 -1.469 . . . . 1.54 107.035 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.3 mmm -59.74 -25.78 65.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.554 -1.276 . . . . 2.4500000000000002 107.554 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.38 -24.75 20.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.784 -0.644 . . . . 2.2999999999999998 111.536 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' HIS . 53.2 m -91.55 -176.0 4.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.014 -1.106 . . . . 0.69999999999999996 108.014 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -108.73 80.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 2.5099999999999998 110.206 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.918 -1.039 . . . . 2.29 110.456 179.654 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.7 pt . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.984 0.421 . . . . 2.9399999999999999 110.982 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.453 ' HD2' HD12 ' A' ' 42' ' ' LEU . 75.9 t60 -149.26 140.69 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 3.7799999999999998 110.315 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.625 ' HA ' HD11 ' A' ' 42' ' ' LEU . 5.7 p -134.11 151.13 51.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.668 -0.697 . . . . 1.4299999999999999 109.357 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.647 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -67.87 115.89 32.61 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 108.081 -1.081 . . . . 0.92000000000000004 108.081 177.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -47.26 -40.8 28.06 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 CA-C-N 120.684 1.28 . . . . 1.3700000000000001 112.815 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.74 -49.18 60.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.639 0.978 . . . . 4.29 113.639 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.61 29.89 3.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.861 0.362 . . . . 1.0 110.535 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -99.26 133.78 11.43 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.314 -0.714 . . . . 0.98999999999999999 111.314 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -168.79 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.518 -0.473 . . . . 3.8199999999999998 110.406 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 m -124.66 9.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.815 -0.629 . . . . 4.4699999999999998 109.86 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.7 mt -77.88 146.79 72.81 Favored Pre-proline 0 C--O 1.225 -0.213 0 C-N-CA 119.261 -0.976 . . . . 3.7999999999999998 110.668 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.8 Cg_exo -36.95 -128.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.803 3.002 . . . . 3.6099999999999999 114.52 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 93.1 m-20 -142.01 -39.71 0.37 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.268 0.47 . . . . 3.0699999999999998 112.268 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.489 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 11.2 pt -146.68 -20.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 2.6200000000000001 111.877 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -71.03 -74.84 0.14 Allowed 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 119.51 -0.876 . . . . 2.2799999999999998 108.715 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 -14.09 59.65 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.027 -0.669 . . . . 2.1299999999999999 109.416 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.637 ' O ' HG13 ' A' ' 46' ' ' VAL . 3.8 mm? -70.86 -42.92 69.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.228 0.537 . . . . 1.9399999999999999 110.072 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 13.5 mm-40 -63.88 -33.6 76.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.625 -0.83 . . . . 2.7799999999999998 108.918 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.5 mm -77.25 -40.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.116 -0.634 . . . . 1.3100000000000001 110.74 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.474 ' ND1' ' CD1' ' A' ' 36' ' ' LEU . 15.3 t-160 -64.6 -46.98 80.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 1.5600000000000001 111.041 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 42' ' ' LEU . 17.0 m -62.52 -29.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.736 -0.386 . . . . 1.54 110.865 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 67.5 mtp -61.76 -35.76 79.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.707 -0.397 . . . . 2.4500000000000002 110.05 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 49' ' ' CYS . 3.3 p30 -94.08 -32.65 13.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.853 -0.339 . . . . 2.2999999999999998 110.458 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 1.3 m -96.64 -174.73 3.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.946 -0.761 . . . . 0.69999999999999996 108.946 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.13 101.86 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.892 -0.41 . . . . 2.5099999999999998 109.892 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.629 ' O ' HG22 ' A' ' 51' ' ' ILE . 86.0 mt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.323 -0.846 . . . . 2.29 109.745 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 26' ' ' ILE . 8.9 tp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.078 0.466 . . . . 2.9399999999999999 110.74 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -149.68 140.15 22.43 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.038 -0.528 . . . . 3.7799999999999998 110.324 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -128.9 160.04 33.91 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.11 -0.496 . . . . 1.4299999999999999 110.113 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' H ' HD22 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -67.49 166.5 21.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.442 -0.345 . . . . 0.92000000000000004 110.106 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.47 -50.98 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.358 1.372 . . . . 1.3700000000000001 111.267 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -109.52 -53.95 2.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.978 -1.01 . . . . 4.29 111.295 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 3.53 5.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.607 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.05 110.1 2.99 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.63 -0.795 . . . . 0.98999999999999999 112.07 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -173.11 -49.8 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.193 -1.04 . . . . 3.8199999999999998 108.193 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 9.54 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.213 -0.903 . . . . 4.4699999999999998 109.965 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 29' ' ' CYS . 10.2 mp -75.9 131.49 76.15 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 119.079 -1.048 . . . . 3.7999999999999998 110.883 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 36' ' ' LEU . 39.7 Cg_exo -42.56 -120.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.156 2.571 . . . . 3.6099999999999999 113.748 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' OD1' HD12 ' A' ' 26' ' ' ILE . 99.7 m-20 -141.57 -47.88 0.38 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.138 0.494 . . . . 3.0699999999999998 111.146 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 pt -144.31 -17.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.474 -0.785 . . . . 2.6200000000000001 112.063 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.74 -81.37 0.06 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.67 -0.812 . . . . 2.2799999999999998 109.279 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -79.71 -5.72 55.78 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.805 -0.758 . . . . 2.1299999999999999 109.119 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.691 HD13 ' C ' ' A' ' 42' ' ' LEU . 2.9 tm? -73.92 -52.57 12.47 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.362 -0.535 . . . . 1.9399999999999999 109.95 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -66.09 -31.69 72.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.822 -0.626 . . . . 2.7799999999999998 110.583 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.12 -49.06 40.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.593 0.711 . . . . 1.3100000000000001 110.584 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 45' ' ' HIS . 23.3 t-160 -67.26 -44.6 78.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.539 -0.755 . . . . 1.5600000000000001 111.818 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.16 -30.65 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.468 -0.493 . . . . 1.54 110.507 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.0 ttp -61.8 -33.85 74.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.49 -0.559 . . . . 2.4500000000000002 109.49 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 67.7 t0 -89.47 -28.12 19.9 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.303 -0.628 . . . . 2.2999999999999998 109.303 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.89 -177.97 5.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.03 -0.729 . . . . 0.69999999999999996 109.03 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.575 ' O ' HG23 ' A' ' 50' ' ' ILE . 14.9 tt -106.52 110.63 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.391 0.615 . . . . 2.5099999999999998 109.805 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.056 -0.974 . . . . 2.29 110.869 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 120.892 0.377 . . . . 2.9399999999999999 110.739 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -151.54 142.24 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 3.7799999999999998 109.871 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 167.2 20.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.114 -0.494 . . . . 1.4299999999999999 109.97 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.679 ' H ' HD12 ' A' ' 36' ' ' LEU . 90.5 m -72.23 159.77 84.51 Favored Pre-proline 0 N--CA 1.473 0.697 0 N-CA-C 108.33 -0.989 . . . . 0.92000000000000004 108.33 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.19 -49.14 16.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.895 1.355 . . . . 1.3700000000000001 112.738 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -113.25 -51.86 2.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.901 0.382 . . . . 4.29 110.129 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -62.94 -5.89 3.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.019 -0.537 . . . . 1.0 109.922 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.72 102.23 1.1 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.516 -0.849 . . . . 0.98999999999999999 111.421 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.41 -50.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.637 -0.825 . . . . 3.8199999999999998 110.564 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.83 12.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.468 -0.787 . . . . 4.4699999999999998 109.898 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 29' ' ' CYS . 10.4 mt -73.67 150.84 88.96 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 118.687 -1.205 . . . . 3.7999999999999998 111.381 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' A' ' 36' ' ' LEU . 77.5 Cg_exo -44.45 -126.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.042 2.494 . . . . 3.6099999999999999 113.435 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 98.1 m-20 -139.87 -59.69 0.55 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.817 -0.552 . . . . 3.0699999999999998 112.26 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 69.3 mt -145.66 -35.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.092 0.472 . . . . 2.6200000000000001 112.034 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -66.28 -81.94 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.884 -0.726 . . . . 2.2799999999999998 109.689 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.48 HG23 ' CG ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -73.31 -10.74 60.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.901 -0.591 . . . . 2.1299999999999999 109.483 178.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.722 HD13 ' C ' ' A' ' 42' ' ' LEU . 2.8 tm? -73.43 -48.74 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.52 -0.472 . . . . 1.9399999999999999 110.132 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 40.4 mm-40 -58.75 -39.04 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.54 -0.755 . . . . 2.7799999999999998 109.065 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -71.32 -40.03 72.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.666 0.746 . . . . 1.3100000000000001 109.858 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.6 ' CD2' ' O ' ' A' ' 45' ' ' HIS . 22.1 t-160 -61.8 -44.75 96.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.732 -0.667 . . . . 1.5600000000000001 112.108 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -56.37 -33.84 39.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.411 -0.589 . . . . 1.54 109.411 -177.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 69.0 mtt -63.19 -28.75 70.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.839 -0.619 . . . . 2.4500000000000002 109.602 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -87.27 -25.23 24.05 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.505 -0.478 . . . . 2.2999999999999998 110.186 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -93.08 -176.04 4.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.155 -0.683 . . . . 0.69999999999999996 109.155 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 tt -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.575 0.703 . . . . 2.5099999999999998 109.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 118.095 -0.955 . . . . 2.29 110.192 179.365 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 120.893 0.378 . . . . 2.9399999999999999 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -141.86 142.15 33.1 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.123 -0.49 . . . . 3.7799999999999998 109.789 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.35 158.32 44.71 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.086 -0.709 . . . . 1.4299999999999999 109.086 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.447 ' N ' ' HA3' ' A' ' 33' ' ' GLY . 12.3 m -68.29 155.06 93.22 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 108.648 -0.871 . . . . 0.92000000000000004 108.648 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -42.31 -62.62 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 CA-C-N 120.494 1.212 . . . . 1.3700000000000001 112.543 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -102.27 -46.98 4.65 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.495 -0.32 . . . . 4.29 111.071 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.54 66.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.891 0.377 . . . . 1.0 110.06 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.447 ' HA3' ' N ' ' A' ' 29' ' ' CYS . . . -68.19 104.1 1.13 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.317 -0.944 . . . . 0.98999999999999999 111.078 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -148.26 -46.33 0.16 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.658 0.742 . . . . 3.8199999999999998 110.293 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.37 12.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.481 -1.236 . . . . 4.4699999999999998 109.552 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 36' ' ' LEU . 3.6 mm? -74.97 152.12 86.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 118.781 -1.167 . . . . 3.7999999999999998 110.365 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.5 Cg_exo -37.98 -137.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.998 3.132 . . . . 3.6099999999999999 115.093 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 90.8 m-20 -139.29 -57.38 0.59 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.684 0.624 . . . . 3.0699999999999998 112.684 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.1 pt -145.04 -34.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.269 0.47 . . . . 2.6200000000000001 112.269 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.39 -75.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.527 0.68 . . . . 2.2799999999999998 110.116 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.455 ' OG1' ' CG ' ' A' ' 37' ' ' PRO . 2.9 p -77.64 -7.13 55.96 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.922 -0.77 . . . . 2.1299999999999999 108.922 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -76.77 -53.33 8.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.137 0.494 . . . . 1.9399999999999999 111.04 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.08 -33.81 69.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.748 -0.834 . . . . 2.7799999999999998 108.748 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mm -72.88 -42.22 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 119.708 -0.797 . . . . 1.3100000000000001 109.585 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.441 ' ND1' HD12 ' A' ' 36' ' ' LEU . 18.7 t-160 -65.06 -45.2 86.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.545 -0.752 . . . . 1.5600000000000001 112.435 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -31.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.427 -0.509 . . . . 1.54 109.742 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 53.5 ttp -62.64 -31.72 72.63 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.762 -0.654 . . . . 2.4500000000000002 109.406 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -88.36 -25.05 22.93 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.182 -0.463 . . . . 2.2999999999999998 110.525 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.41 -176.49 4.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.553 -0.906 . . . . 0.69999999999999996 108.553 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -107.38 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.479 . . . . 2.5099999999999998 110.081 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 118.013 -0.994 . . . . 2.29 110.574 -179.942 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 26' ' ' ILE . 2.1 pp . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 121.166 0.508 . . . . 2.9399999999999999 110.608 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.527 ' O ' HD22 ' A' ' 42' ' ' LEU . 78.8 m80 -158.77 139.95 13.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 3.7799999999999998 110.223 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 34' ' ' GLU . 5.0 p -116.67 155.11 29.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.746 -0.465 . . . . 1.4299999999999999 109.746 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -69.16 133.79 89.58 Favored Pre-proline 0 C--O 1.214 -0.781 0 N-CA-C 106.697 -1.594 . . . . 0.92000000000000004 106.697 177.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -35.6 23.85 Favored 'Trans proline' 0 C--N 1.298 -2.122 0 CA-C-N 121.02 1.4 . . . . 1.3700000000000001 113.388 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -63.48 -40.87 98.24 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.14 0.422 . . . . 4.29 112.14 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 -15.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.712 0.291 . . . . 1.0 111.471 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -91.43 150.81 20.61 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 110.157 -1.177 . . . . 0.98999999999999999 110.157 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' ' OG ' ' A' ' 28' ' ' SER . 82.8 mt-10 -155.49 -46.46 0.08 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.562 0.696 . . . . 3.8199999999999998 110.381 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.03 9.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.675 -1.148 . . . . 4.4699999999999998 110.015 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 mt -108.27 84.06 2.13 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 119.887 -0.725 . . . . 3.7999999999999998 112.405 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.35 128.51 8.07 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.282 1.988 . . . . 3.6099999999999999 111.747 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 40' ' ' ASP . 6.0 m-20 -142.61 35.1 1.44 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 112.933 0.716 . . . . 3.0699999999999998 112.933 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 40' ' ' ASP . 9.0 tp -9.4 -37.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 124.676 1.235 . . . . 2.6200000000000001 113.548 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.817 ' N ' ' O ' ' A' ' 38' ' ' ASP . 64.5 t0 -76.73 -61.45 1.96 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.496 -1.298 . . . . 2.2799999999999998 107.496 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.619 ' N ' ' O ' ' A' ' 38' ' ' ASP . 4.8 m -78.41 -23.18 46.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.897 -0.592 . . . . 2.1299999999999999 110.266 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.527 HD22 ' O ' ' A' ' 27' ' ' HIS . 8.2 tp -71.16 -50.51 32.54 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 120.944 -0.302 . . . . 1.9399999999999999 110.819 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.06 -24.88 64.93 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.92 -0.77 . . . . 2.7799999999999998 108.92 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.05 -38.23 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.628 -0.714 . . . . 1.3100000000000001 109.188 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -65.58 -47.42 75.83 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.913 -0.585 . . . . 1.5600000000000001 111.007 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' CYS . 8.5 p -62.04 -31.51 51.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.418 . . . . 1.54 110.543 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.04 -34.16 74.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.761 -0.459 . . . . 2.4500000000000002 109.761 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.83 -29.38 16.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 2.2999999999999998 110.169 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 46' ' ' VAL . 1.4 m -92.72 -179.67 5.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.176 -1.046 . . . . 0.69999999999999996 108.176 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.413 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 47.8 mm -108.33 101.2 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.948 0.404 . . . . 2.5099999999999998 110.422 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.413 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 20.3 tt . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.992 -1.004 . . . . 2.29 110.622 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 109.696 -0.483 . . . . 2.9399999999999999 109.696 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -142.64 146.08 34.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.446 -0.576 . . . . 3.7799999999999998 109.446 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.24 153.88 44.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.477 -0.328 . . . . 1.4299999999999999 110.278 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -89.87 109.01 29.48 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 120.142 -0.623 . . . . 0.92000000000000004 109.382 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' C ' ' O ' ' A' ' 29' ' ' CYS . 54.0 Cg_exo -37.02 -29.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 CA-C-N 121.076 1.42 . . . . 1.3700000000000001 112.265 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' CYS . 52.7 tptt -65.24 -45.21 85.51 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.142 -0.481 . . . . 4.29 111.394 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.467 ' O ' HD11 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -149.85 14.37 0.83 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.796 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -59.47 111.91 3.84 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.889 -0.596 . . . . 0.98999999999999999 111.927 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -155.67 -52.29 0.09 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.66 0.743 . . . . 3.8199999999999998 110.991 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.21 11.37 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.599 -1.182 . . . . 4.4699999999999998 111.16 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.927 ' H ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.06 157.97 82.7 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 119.118 -1.033 . . . . 3.7999999999999998 110.917 -178.495 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -22.97 -134.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 125.191 3.927 . . . . 3.6099999999999999 115.332 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 85.4 m-20 -143.31 -59.19 0.42 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.19 0.811 . . . . 3.0699999999999998 113.19 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -144.32 -41.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.226 0.454 . . . . 2.6200000000000001 112.226 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.71 -74.26 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.263 -0.575 . . . . 2.2799999999999998 110.463 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.9 m -69.39 -17.49 63.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.161 -0.681 . . . . 2.1299999999999999 109.161 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -68.73 -49.48 58.45 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.783 -0.644 . . . . 1.9399999999999999 110.024 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -54.98 -33.16 62.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.335 -0.987 . . . . 2.7799999999999998 108.335 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.0 -31.28 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.086 -0.645 . . . . 1.3100000000000001 109.713 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -66.51 -47.2 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 1.5600000000000001 111.508 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -59.37 -33.53 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.905 -0.718 . . . . 1.54 109.876 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -31.25 71.49 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.863 -0.608 . . . . 2.4500000000000002 109.746 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.04 -23.83 21.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.715 0.293 . . . . 2.2999999999999998 110.223 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -178.67 5.14 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.035 -0.728 . . . . 0.69999999999999996 109.035 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -110.57 92.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.032 -0.359 . . . . 2.5099999999999998 110.032 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.971 -1.014 . . . . 2.29 110.71 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.0 tt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.928 0.394 . . . . 2.9399999999999999 111.714 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.538 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 p-80 -77.22 86.76 3.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.735 -0.666 . . . . 3.7799999999999998 112.096 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.697 ' O ' HD21 ' A' ' 42' ' ' LEU . 13.2 p -156.79 162.31 39.74 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 121.721 0.772 . . . . 1.4299999999999999 111.802 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -153.09 115.95 2.77 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 106.297 -1.742 . . . . 0.92000000000000004 106.297 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -47.08 -41.27 26.72 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 121.448 1.553 . . . . 1.3700000000000001 112.534 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HG2' HG22 ' A' ' 50' ' ' ILE . 70.0 mmtt -67.3 -42.51 83.61 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.094 0.776 . . . . 4.29 113.094 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -138.83 33.26 2.2 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 1.0 110.203 -177.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -74.94 100.52 1.23 Allowed Glycine 0 C--O 1.23 -0.123 0 CA-C-N 115.714 -0.675 . . . . 0.98999999999999999 111.906 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -154.39 -53.66 0.1 Allowed 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.901 0.858 . . . . 3.8199999999999998 109.287 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 9.31 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.972 -1.467 . . . . 4.4699999999999998 109.833 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 mm? -79.19 118.55 73.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 119.587 -0.845 . . . . 3.7999999999999998 111.066 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 36' ' ' LEU . 72.8 Cg_exo -47.16 -150.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.128 2.552 . . . . 3.6099999999999999 112.992 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.891 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -143.25 -71.63 0.31 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.909 1.337 . . . . 3.0699999999999998 112.995 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 38' ' ' ASP . 96.9 mt -27.81 -62.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.53 -1.214 . . . . 2.6200000000000001 111.9 -178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.0 -27.51 22.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.95 -1.023 . . . . 2.2799999999999998 109.081 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 45' ' ' HIS . 29.5 m -82.72 -66.31 0.91 Allowed 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 114.073 -1.421 . . . . 2.1299999999999999 110.239 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.891 ' N ' ' O ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -50.53 -34.59 25.93 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.088 -1.045 . . . . 1.9399999999999999 109.936 -178.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -65.52 -63.5 1.08 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.693 -0.803 . . . . 2.7799999999999998 112.221 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 62.4 mt -86.19 -35.26 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.694 0.627 . . . . 1.3100000000000001 112.694 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 41' ' ' THR . 9.7 t-160 -58.6 -43.56 89.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.95 -0.568 . . . . 1.5600000000000001 110.137 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 42' ' ' LEU . 21.0 m -63.62 -39.34 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 119.693 -0.803 . . . . 1.54 110.05 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.451 ' N ' HG23 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -51.79 -28.38 15.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 119.489 -0.884 . . . . 2.4500000000000002 109.958 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 1.2 p-10 -104.39 -34.5 8.26 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.933 -0.307 . . . . 2.2999999999999998 111.376 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 46' ' ' VAL . 42.6 m -94.85 -176.18 3.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.741 -0.837 . . . . 0.69999999999999996 108.741 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 50' ' ' ILE . 8.8 tp -100.41 87.08 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.299 0.571 . . . . 2.5099999999999998 110.018 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.168 -0.92 . . . . 2.29 110.034 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.533 ' O ' ' CG ' ' A' ' 27' ' ' HIS . 2.2 pp . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 108.792 -0.818 . . . . 2.9399999999999999 108.792 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 99.2 m-70 -158.69 130.72 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 3.7799999999999998 110.477 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -95.34 160.81 14.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.434 -0.58 . . . . 1.4299999999999999 109.434 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.476 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -66.49 175.54 1.31 Allowed Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 108.836 -0.801 . . . . 0.92000000000000004 108.836 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' GLY . 26.1 Cg_endo -83.41 -73.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.127 1.218 . . . . 1.3700000000000001 110.18 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.86 -44.9 65.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.845 -0.616 . . . . 4.29 110.879 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -46.56 52.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.192 0.52 . . . . 1.0 111.75 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . -114.66 -178.02 18.92 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 110.431 -1.067 . . . . 0.98999999999999999 110.431 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -174.12 -47.63 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.946 -0.761 . . . . 3.8199999999999998 108.946 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.2 10.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.739 -1.119 . . . . 4.4699999999999998 109.647 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.3 mt -115.73 73.41 4.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 113.232 0.827 . . . . 3.7999999999999998 113.232 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -87.53 117.17 1.19 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 123.146 2.564 . . . . 3.6099999999999999 110.986 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -85.45 -77.91 0.28 Allowed 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 118.015 -1.474 . . . . 3.0699999999999998 111.196 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.1 mt -154.45 -87.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.952 1.358 . . . . 2.6200000000000001 110.309 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.86 -24.77 13.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.261 -1.791 . . . . 2.2799999999999998 111.175 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -65.41 -44.01 88.77 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.734 -0.786 . . . . 2.1299999999999999 109.071 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.48 -41.14 61.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.858 -0.61 . . . . 1.9399999999999999 111.029 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.46 -41.05 89.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.508 -0.877 . . . . 2.7799999999999998 110.031 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.5 -42.2 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.235 0.541 . . . . 1.3100000000000001 110.572 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 45' ' ' HIS . 20.6 t-160 -60.67 -46.42 90.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 1.5600000000000001 111.55 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -32.82 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.319 -0.552 . . . . 1.54 110.987 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.15 -35.66 77.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.1 -0.5 . . . . 2.4500000000000002 109.874 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -92.73 -10.89 35.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.886 -0.412 . . . . 2.2999999999999998 109.886 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.11 -178.84 4.61 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.65 -0.871 . . . . 0.69999999999999996 108.65 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.414 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -109.78 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.911 0.386 . . . . 2.5099999999999998 110.503 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.414 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 96.0 mt . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.088 -0.958 . . . . 2.29 111.449 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.601 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 110.1 -0.333 . . . . 4.8200000000000003 110.1 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 24' ' ' ILE . 83.0 Cg_endo -88.49 -177.32 1.73 Allowed 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.442 2.095 . . . . 3.77 111.941 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 pt -124.83 160.26 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.15 0.5 . . . . 2.9399999999999999 110.969 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.632 ' ND1' HD12 ' A' ' 42' ' ' LEU . 62.9 t-80 -158.3 149.22 20.67 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.543 -0.753 . . . . 3.7799999999999998 109.994 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -136.97 137.04 39.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.917 -0.772 . . . . 1.4299999999999999 108.917 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -65.59 115.39 21.81 Favored Pre-proline 0 C--O 1.214 -0.795 0 N-CA-C 107.246 -1.39 . . . . 0.92000000000000004 107.246 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.71 -41.63 14.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 120.533 1.226 . . . . 1.3700000000000001 112.713 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.19 -44.52 79.45 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.783 0.66 . . . . 4.29 112.783 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 32.11 1.17 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.195 0.522 . . . . 1.0 111.298 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -76.22 120.39 5.86 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 109.903 -1.279 . . . . 0.98999999999999999 109.903 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 10.7 mt-10 153.49 -37.96 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.663 -1.606 . . . . 3.8199999999999998 106.663 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.93 -31.39 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 113.144 -1.843 . . . . 4.4699999999999998 108.249 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -172.26 72.12 0.45 Allowed Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 117.945 -1.502 . . . . 3.7999999999999998 111.814 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' CB ' ' O ' ' A' ' 27' ' ' HIS . 87.1 Cg_endo -88.29 67.28 3.21 Favored 'Trans proline' 0 C--N 1.291 -2.49 0 C-N-CA 122.008 1.805 . . . . 3.6099999999999999 112.381 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 4.6 p-10 -88.02 -77.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.513 0.931 . . . . 3.0699999999999998 113.513 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.444 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 41.5 mt -156.05 -77.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 122.404 1.097 . . . . 2.6200000000000001 111.32 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -88.01 -34.43 18.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 112.962 -1.926 . . . . 2.2799999999999998 111.965 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -61.15 -40.42 93.77 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.539 -0.911 . . . . 2.1299999999999999 108.539 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -67.61 -42.1 82.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 1.9399999999999999 109.758 179.208 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -57.77 -29.47 64.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.471 -0.892 . . . . 2.7799999999999998 109.171 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.48 -38.82 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.234 0.54 . . . . 1.3100000000000001 109.555 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -63.27 -48.73 76.94 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.677 -0.692 . . . . 1.5600000000000001 111.605 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 49' ' ' CYS . 1.6 p -61.21 -32.81 53.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.269 -0.423 . . . . 1.54 110.655 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.9 ttp -61.85 -34.36 75.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.201 -0.454 . . . . 2.4500000000000002 110.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 66.3 t0 -90.9 -23.74 20.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.443 -0.577 . . . . 2.2999999999999998 109.443 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.527 ' C ' HD12 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -91.95 163.24 14.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.507 -0.923 . . . . 0.69999999999999996 108.507 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.753 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.9 mp -103.84 86.4 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.387 -0.597 . . . . 2.5099999999999998 109.387 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 118.319 -0.848 . . . . 2.29 110.089 -179.52 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 108.412 -0.958 . . . . 4.8200000000000003 108.412 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.84 145.93 97.0 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.527 1.485 . . . . 3.77 111.64 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.403 ' CD1' ' OD1' ' A' ' 38' ' ' ASP . 44.2 mm -112.75 129.85 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 2.9399999999999999 110.845 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -147.98 127.63 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.638 -0.71 . . . . 3.7799999999999998 109.853 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.88 156.84 39.01 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.554 -0.748 . . . . 1.4299999999999999 109.245 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.439 ' H ' HD12 ' A' ' 36' ' ' LEU . 24.6 m -72.77 155.76 90.5 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 108.949 -0.76 . . . . 0.92000000000000004 108.949 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.7 -61.27 0.55 Allowed 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 119.857 0.985 . . . . 1.3700000000000001 111.995 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -99.94 -18.95 16.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.207 0.447 . . . . 4.29 112.207 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -100.5 -10.75 20.75 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.739 0.304 . . . . 1.0 110.488 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.36 94.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.428 -0.891 . . . . 0.98999999999999999 111.242 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -163.63 -45.5 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.921 -0.77 . . . . 3.8199999999999998 108.921 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -103.56 3.6 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.298 -0.865 . . . . 4.4699999999999998 110.36 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.631 ' CD1' ' HE2' ' A' ' 45' ' ' HIS . 16.0 mt -79.89 149.27 70.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 118.63 -1.228 . . . . 3.7999999999999998 112.126 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 91.0 Cg_endo -76.33 -99.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.019 1.813 . . . . 3.6099999999999999 112.86 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.844 ' O ' HD13 ' A' ' 39' ' ' ILE . 72.7 m-20 -143.38 -54.7 0.39 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.55 1.315 . . . . 3.0699999999999998 114.55 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.844 HD13 ' O ' ' A' ' 38' ' ' ASP . 6.9 mm -143.01 -24.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.191 0.441 . . . . 2.6200000000000001 112.191 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.78 -83.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.233 -0.439 . . . . 2.2799999999999998 110.632 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -73.74 -4.35 33.97 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.348 -0.982 . . . . 2.1299999999999999 108.348 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.704 HD13 ' C ' ' A' ' 42' ' ' LEU . 2.3 tm? -76.08 -55.37 5.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.299 -0.864 . . . . 1.9399999999999999 110.146 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.453 ' N ' HD13 ' A' ' 42' ' ' LEU . 78.4 mt-30 -68.63 -39.12 80.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.444 -0.798 . . . . 2.7799999999999998 111.873 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.84 -51.07 48.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.499 0.666 . . . . 1.3100000000000001 112.014 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.631 ' HE2' ' CD1' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.81 -20.21 63.46 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.794 0.807 . . . . 1.5600000000000001 110.636 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.619 ' N ' ' ND1' ' A' ' 45' ' ' HIS . 1.2 t -57.91 -43.88 85.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.035 -1.469 . . . . 1.54 107.035 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.3 mmm -59.74 -25.78 65.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.554 -1.276 . . . . 2.4500000000000002 107.554 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.38 -24.75 20.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.784 -0.644 . . . . 2.2999999999999998 111.536 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' HIS . 53.2 m -91.55 -176.0 4.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.014 -1.106 . . . . 0.69999999999999996 108.014 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -108.73 80.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 2.5099999999999998 110.206 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.918 -1.039 . . . . 2.29 110.456 179.654 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 24' ' ' ILE . 16.3 mt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.098 -0.704 . . . . 4.8200000000000003 109.098 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.04 156.2 47.43 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.738 2.292 . . . . 3.77 112.196 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.7 pt -77.4 166.92 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 2.9399999999999999 110.982 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.453 ' HD2' HD12 ' A' ' 42' ' ' LEU . 75.9 t60 -149.26 140.69 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 3.7799999999999998 110.315 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.625 ' HA ' HD11 ' A' ' 42' ' ' LEU . 5.7 p -134.11 151.13 51.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.668 -0.697 . . . . 1.4299999999999999 109.357 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.647 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -67.87 115.89 32.61 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 108.081 -1.081 . . . . 0.92000000000000004 108.081 177.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -47.26 -40.8 28.06 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 CA-C-N 120.684 1.28 . . . . 1.3700000000000001 112.815 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.74 -49.18 60.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.639 0.978 . . . . 4.29 113.639 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.61 29.89 3.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.861 0.362 . . . . 1.0 110.535 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -99.26 133.78 11.43 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.314 -0.714 . . . . 0.98999999999999999 111.314 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -168.79 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.518 -0.473 . . . . 3.8199999999999998 110.406 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 m -124.66 9.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.815 -0.629 . . . . 4.4699999999999998 109.86 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.7 mt -77.88 146.79 72.81 Favored Pre-proline 0 C--O 1.225 -0.213 0 C-N-CA 119.261 -0.976 . . . . 3.7999999999999998 110.668 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.8 Cg_exo -36.95 -128.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.803 3.002 . . . . 3.6099999999999999 114.52 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 93.1 m-20 -142.01 -39.71 0.37 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.268 0.47 . . . . 3.0699999999999998 112.268 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.489 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 11.2 pt -146.68 -20.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 2.6200000000000001 111.877 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -71.03 -74.84 0.14 Allowed 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 119.51 -0.876 . . . . 2.2799999999999998 108.715 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 -14.09 59.65 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.027 -0.669 . . . . 2.1299999999999999 109.416 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.637 ' O ' HG13 ' A' ' 46' ' ' VAL . 3.8 mm? -70.86 -42.92 69.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.228 0.537 . . . . 1.9399999999999999 110.072 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 13.5 mm-40 -63.88 -33.6 76.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.625 -0.83 . . . . 2.7799999999999998 108.918 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.5 mm -77.25 -40.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.116 -0.634 . . . . 1.3100000000000001 110.74 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.474 ' ND1' ' CD1' ' A' ' 36' ' ' LEU . 15.3 t-160 -64.6 -46.98 80.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 1.5600000000000001 111.041 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 42' ' ' LEU . 17.0 m -62.52 -29.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.736 -0.386 . . . . 1.54 110.865 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 67.5 mtp -61.76 -35.76 79.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.707 -0.397 . . . . 2.4500000000000002 110.05 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 49' ' ' CYS . 3.3 p30 -94.08 -32.65 13.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.853 -0.339 . . . . 2.2999999999999998 110.458 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 1.3 m -96.64 -174.73 3.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.946 -0.761 . . . . 0.69999999999999996 108.946 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.13 101.86 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.892 -0.41 . . . . 2.5099999999999998 109.892 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.629 ' O ' HG22 ' A' ' 51' ' ' ILE . 86.0 mt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.323 -0.846 . . . . 2.29 109.745 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.5 mm . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.158 -0.682 . . . . 4.8200000000000003 109.158 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.88 143.86 37.6 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.44 2.093 . . . . 3.77 111.862 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 26' ' ' ILE . 8.9 tp -91.48 127.63 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 121.078 0.466 . . . . 2.9399999999999999 110.74 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -149.68 140.15 22.43 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.038 -0.528 . . . . 3.7799999999999998 110.324 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -128.9 160.04 33.91 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.11 -0.496 . . . . 1.4299999999999999 110.113 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' H ' HD22 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -67.49 166.5 21.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.442 -0.345 . . . . 0.92000000000000004 110.106 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.47 -50.98 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.358 1.372 . . . . 1.3700000000000001 111.267 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -109.52 -53.95 2.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.978 -1.01 . . . . 4.29 111.295 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 3.53 5.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.607 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.05 110.1 2.99 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.63 -0.795 . . . . 0.98999999999999999 112.07 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -173.11 -49.8 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.193 -1.04 . . . . 3.8199999999999998 108.193 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 9.54 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.213 -0.903 . . . . 4.4699999999999998 109.965 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 29' ' ' CYS . 10.2 mp -75.9 131.49 76.15 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 119.079 -1.048 . . . . 3.7999999999999998 110.883 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 36' ' ' LEU . 39.7 Cg_exo -42.56 -120.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.156 2.571 . . . . 3.6099999999999999 113.748 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' OD1' HD12 ' A' ' 26' ' ' ILE . 99.7 m-20 -141.57 -47.88 0.38 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.138 0.494 . . . . 3.0699999999999998 111.146 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 pt -144.31 -17.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.474 -0.785 . . . . 2.6200000000000001 112.063 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.74 -81.37 0.06 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.67 -0.812 . . . . 2.2799999999999998 109.279 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -79.71 -5.72 55.78 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.805 -0.758 . . . . 2.1299999999999999 109.119 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.691 HD13 ' C ' ' A' ' 42' ' ' LEU . 2.9 tm? -73.92 -52.57 12.47 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.362 -0.535 . . . . 1.9399999999999999 109.95 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -66.09 -31.69 72.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.822 -0.626 . . . . 2.7799999999999998 110.583 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.12 -49.06 40.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.593 0.711 . . . . 1.3100000000000001 110.584 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -67.26 -44.6 78.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.539 -0.755 . . . . 1.5600000000000001 111.818 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.16 -30.65 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.468 -0.493 . . . . 1.54 110.507 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.0 ttp -61.8 -33.85 74.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.49 -0.559 . . . . 2.4500000000000002 109.49 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 67.7 t0 -89.47 -28.12 19.9 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.303 -0.628 . . . . 2.2999999999999998 109.303 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.89 -177.97 5.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.03 -0.729 . . . . 0.69999999999999996 109.03 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.575 ' O ' HG23 ' A' ' 50' ' ' ILE . 14.9 tt -106.52 110.63 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.391 0.615 . . . . 2.5099999999999998 109.805 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.056 -0.974 . . . . 2.29 110.869 -179.875 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.564 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 mp . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 110.236 -0.283 . . . . 4.8200000000000003 110.236 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 24' ' ' ILE . 91.3 Cg_endo -85.06 155.53 11.23 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.389 1.393 . . . . 3.77 112.308 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 pt -131.15 166.04 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.787 -0.642 . . . . 2.9399999999999999 110.739 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -151.54 142.24 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 3.7799999999999998 109.871 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 167.2 20.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.114 -0.494 . . . . 1.4299999999999999 109.97 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.679 ' H ' HD12 ' A' ' 36' ' ' LEU . 90.5 m -72.23 159.77 84.51 Favored Pre-proline 0 N--CA 1.473 0.697 0 N-CA-C 108.33 -0.989 . . . . 0.92000000000000004 108.33 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.19 -49.14 16.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.895 1.355 . . . . 1.3700000000000001 112.738 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -113.25 -51.86 2.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.901 0.382 . . . . 4.29 110.129 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -62.94 -5.89 3.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.019 -0.537 . . . . 1.0 109.922 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.72 102.23 1.1 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.516 -0.849 . . . . 0.98999999999999999 111.421 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.41 -50.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.637 -0.825 . . . . 3.8199999999999998 110.564 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.83 12.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.468 -0.787 . . . . 4.4699999999999998 109.898 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 29' ' ' CYS . 10.4 mt -73.67 150.84 88.96 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 118.687 -1.205 . . . . 3.7999999999999998 111.381 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' A' ' 36' ' ' LEU . 77.5 Cg_exo -44.45 -126.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.042 2.494 . . . . 3.6099999999999999 113.435 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 98.1 m-20 -139.87 -59.69 0.55 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.817 -0.552 . . . . 3.0699999999999998 112.26 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 69.3 mt -145.66 -35.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.092 0.472 . . . . 2.6200000000000001 112.034 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -66.28 -81.94 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.884 -0.726 . . . . 2.2799999999999998 109.689 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.48 HG23 ' CG ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -73.31 -10.74 60.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.901 -0.591 . . . . 2.1299999999999999 109.483 178.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.722 HD13 ' C ' ' A' ' 42' ' ' LEU . 2.8 tm? -73.43 -48.74 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.52 -0.472 . . . . 1.9399999999999999 110.132 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 40.4 mm-40 -58.75 -39.04 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.54 -0.755 . . . . 2.7799999999999998 109.065 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -71.32 -40.03 72.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.666 0.746 . . . . 1.3100000000000001 109.858 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.404 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 1.3 t60 -61.8 -44.75 96.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.732 -0.667 . . . . 1.5600000000000001 112.108 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -56.37 -33.84 39.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.411 -0.589 . . . . 1.54 109.411 -177.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 69.0 mtt -63.19 -28.75 70.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.839 -0.619 . . . . 2.4500000000000002 109.602 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -87.27 -25.23 24.05 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.505 -0.478 . . . . 2.2999999999999998 110.186 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -93.08 -176.04 4.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.155 -0.683 . . . . 0.69999999999999996 109.155 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 tt -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.575 0.703 . . . . 2.5099999999999998 109.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 118.095 -0.955 . . . . 2.29 110.192 179.365 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 25' ' ' PRO . 9.1 tt . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 108.099 -1.075 . . . . 4.8200000000000003 108.099 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 24' ' ' ILE . 17.4 Cg_exo -29.72 123.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.69 2.26 . . . . 3.77 113.952 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.0 tt -130.06 139.81 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.09 -0.959 . . . . 2.9399999999999999 110.543 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -141.86 142.15 33.1 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.123 -0.49 . . . . 3.7799999999999998 109.789 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.35 158.32 44.71 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.086 -0.709 . . . . 1.4299999999999999 109.086 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.447 ' N ' ' HA3' ' A' ' 33' ' ' GLY . 12.3 m -68.29 155.06 93.22 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 108.648 -0.871 . . . . 0.92000000000000004 108.648 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -42.31 -62.62 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 CA-C-N 120.494 1.212 . . . . 1.3700000000000001 112.543 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -102.27 -46.98 4.65 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.495 -0.32 . . . . 4.29 111.071 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.54 66.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.891 0.377 . . . . 1.0 110.06 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.447 ' HA3' ' N ' ' A' ' 29' ' ' CYS . . . -68.19 104.1 1.13 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.317 -0.944 . . . . 0.98999999999999999 111.078 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -148.26 -46.33 0.16 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.658 0.742 . . . . 3.8199999999999998 110.293 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.37 12.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.481 -1.236 . . . . 4.4699999999999998 109.552 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 36' ' ' LEU . 3.6 mm? -74.97 152.12 86.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 118.781 -1.167 . . . . 3.7999999999999998 110.365 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.5 Cg_exo -37.98 -137.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.998 3.132 . . . . 3.6099999999999999 115.093 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 90.8 m-20 -139.29 -57.38 0.59 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.684 0.624 . . . . 3.0699999999999998 112.684 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.1 pt -145.04 -34.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.269 0.47 . . . . 2.6200000000000001 112.269 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.39 -75.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.527 0.68 . . . . 2.2799999999999998 110.116 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.455 ' OG1' ' CG ' ' A' ' 37' ' ' PRO . 2.9 p -77.64 -7.13 55.96 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.922 -0.77 . . . . 2.1299999999999999 108.922 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -76.77 -53.33 8.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.137 0.494 . . . . 1.9399999999999999 111.04 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.08 -33.81 69.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.748 -0.834 . . . . 2.7799999999999998 108.748 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mm -72.88 -42.22 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 119.708 -0.797 . . . . 1.3100000000000001 109.585 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.641 ' CD2' HD12 ' A' ' 36' ' ' LEU . 3.7 t60 -65.06 -45.2 86.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.545 -0.752 . . . . 1.5600000000000001 112.435 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -31.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.427 -0.509 . . . . 1.54 109.742 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 53.5 ttp -62.64 -31.72 72.63 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.762 -0.654 . . . . 2.4500000000000002 109.406 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -88.36 -25.05 22.93 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.182 -0.463 . . . . 2.2999999999999998 110.525 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.41 -176.49 4.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.553 -0.906 . . . . 0.69999999999999996 108.553 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -107.38 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.479 . . . . 2.5099999999999998 110.081 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 118.013 -0.994 . . . . 2.29 110.574 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.647 -0.871 . . . . 4.8200000000000003 108.647 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.25 151.72 66.42 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.36 2.04 . . . . 3.77 111.969 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 26' ' ' ILE . 2.1 pp -118.23 115.77 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.166 0.508 . . . . 2.9399999999999999 110.608 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.527 ' O ' HD22 ' A' ' 42' ' ' LEU . 78.8 m80 -158.77 139.95 13.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 3.7799999999999998 110.223 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 34' ' ' GLU . 5.0 p -116.67 155.11 29.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.746 -0.465 . . . . 1.4299999999999999 109.746 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -69.16 133.79 89.58 Favored Pre-proline 0 C--O 1.214 -0.781 0 N-CA-C 106.697 -1.594 . . . . 0.92000000000000004 106.697 177.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -35.6 23.85 Favored 'Trans proline' 0 C--N 1.298 -2.122 0 CA-C-N 121.02 1.4 . . . . 1.3700000000000001 113.388 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -63.48 -40.87 98.24 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.14 0.422 . . . . 4.29 112.14 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 -15.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.712 0.291 . . . . 1.0 111.471 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -91.43 150.81 20.61 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 110.157 -1.177 . . . . 0.98999999999999999 110.157 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' ' OG ' ' A' ' 28' ' ' SER . 82.8 mt-10 -155.49 -46.46 0.08 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.562 0.696 . . . . 3.8199999999999998 110.381 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.03 9.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.675 -1.148 . . . . 4.4699999999999998 110.015 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 mt -108.27 84.06 2.13 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 119.887 -0.725 . . . . 3.7999999999999998 112.405 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.35 128.51 8.07 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.282 1.988 . . . . 3.6099999999999999 111.747 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 40' ' ' ASP . 6.0 m-20 -142.61 35.1 1.44 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 112.933 0.716 . . . . 3.0699999999999998 112.933 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 40' ' ' ASP . 9.0 tp -9.4 -37.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 124.676 1.235 . . . . 2.6200000000000001 113.548 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.817 ' N ' ' O ' ' A' ' 38' ' ' ASP . 64.5 t0 -76.73 -61.45 1.96 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.496 -1.298 . . . . 2.2799999999999998 107.496 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.619 ' N ' ' O ' ' A' ' 38' ' ' ASP . 4.8 m -78.41 -23.18 46.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.897 -0.592 . . . . 2.1299999999999999 110.266 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.527 HD22 ' O ' ' A' ' 27' ' ' HIS . 8.2 tp -71.16 -50.51 32.54 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 120.944 -0.302 . . . . 1.9399999999999999 110.819 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.06 -24.88 64.93 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.92 -0.77 . . . . 2.7799999999999998 108.92 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.05 -38.23 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.628 -0.714 . . . . 1.3100000000000001 109.188 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -65.58 -47.42 75.83 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.913 -0.585 . . . . 1.5600000000000001 111.007 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' CYS . 8.5 p -62.04 -31.51 51.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.418 . . . . 1.54 110.543 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.04 -34.16 74.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.761 -0.459 . . . . 2.4500000000000002 109.761 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.83 -29.38 16.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 2.2999999999999998 110.169 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 46' ' ' VAL . 1.4 m -92.72 -179.67 5.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.176 -1.046 . . . . 0.69999999999999996 108.176 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.413 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 47.8 mm -108.33 101.2 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.948 0.404 . . . . 2.5099999999999998 110.422 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.413 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 20.3 tt . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.992 -1.004 . . . . 2.29 110.622 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 mm . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.577 -0.527 . . . . 4.8200000000000003 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.34 125.08 16.04 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 121.669 1.579 . . . . 3.77 112.528 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.3 pt -140.88 163.2 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.696 -0.483 . . . . 2.9399999999999999 109.696 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -142.64 146.08 34.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.446 -0.576 . . . . 3.7799999999999998 109.446 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.24 153.88 44.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.477 -0.328 . . . . 1.4299999999999999 110.278 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -89.87 109.01 29.48 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 120.142 -0.623 . . . . 0.92000000000000004 109.382 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' C ' ' O ' ' A' ' 29' ' ' CYS . 54.0 Cg_exo -37.02 -29.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 CA-C-N 121.076 1.42 . . . . 1.3700000000000001 112.265 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' CYS . 52.7 tptt -65.24 -45.21 85.51 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.142 -0.481 . . . . 4.29 111.394 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.467 ' O ' HD11 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -149.85 14.37 0.83 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.796 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -59.47 111.91 3.84 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.889 -0.596 . . . . 0.98999999999999999 111.927 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -155.67 -52.29 0.09 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.66 0.743 . . . . 3.8199999999999998 110.991 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.21 11.37 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.599 -1.182 . . . . 4.4699999999999998 111.16 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.927 ' H ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.06 157.97 82.7 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 119.118 -1.033 . . . . 3.7999999999999998 110.917 -178.495 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -22.97 -134.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 125.191 3.927 . . . . 3.6099999999999999 115.332 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 85.4 m-20 -143.31 -59.19 0.42 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.19 0.811 . . . . 3.0699999999999998 113.19 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -144.32 -41.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.226 0.454 . . . . 2.6200000000000001 112.226 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.71 -74.26 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.263 -0.575 . . . . 2.2799999999999998 110.463 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.9 m -69.39 -17.49 63.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.161 -0.681 . . . . 2.1299999999999999 109.161 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -68.73 -49.48 58.45 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.783 -0.644 . . . . 1.9399999999999999 110.024 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -54.98 -33.16 62.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.335 -0.987 . . . . 2.7799999999999998 108.335 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.0 -31.28 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.086 -0.645 . . . . 1.3100000000000001 109.713 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -66.51 -47.2 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 1.5600000000000001 111.508 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -59.37 -33.53 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.905 -0.718 . . . . 1.54 109.876 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -31.25 71.49 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.863 -0.608 . . . . 2.4500000000000002 109.746 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.04 -23.83 21.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.715 0.293 . . . . 2.2999999999999998 110.223 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -178.67 5.14 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.035 -0.728 . . . . 0.69999999999999996 109.035 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -110.57 92.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.032 -0.359 . . . . 2.5099999999999998 110.032 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.971 -1.014 . . . . 2.29 110.71 -179.987 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.4 mp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.438 -0.578 . . . . 4.8200000000000003 109.438 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.31 172.01 11.87 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.94 2.426 . . . . 3.77 111.433 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.0 tt -61.18 160.07 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.928 0.394 . . . . 2.9399999999999999 111.714 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.538 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 p-80 -77.22 86.76 3.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.735 -0.666 . . . . 3.7799999999999998 112.096 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.697 ' O ' HD21 ' A' ' 42' ' ' LEU . 13.2 p -156.79 162.31 39.74 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 121.721 0.772 . . . . 1.4299999999999999 111.802 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -153.09 115.95 2.77 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 106.297 -1.742 . . . . 0.92000000000000004 106.297 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -47.08 -41.27 26.72 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 121.448 1.553 . . . . 1.3700000000000001 112.534 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HG2' HG22 ' A' ' 50' ' ' ILE . 70.0 mmtt -67.3 -42.51 83.61 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.094 0.776 . . . . 4.29 113.094 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -138.83 33.26 2.2 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 1.0 110.203 -177.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -74.94 100.52 1.23 Allowed Glycine 0 C--O 1.23 -0.123 0 CA-C-N 115.714 -0.675 . . . . 0.98999999999999999 111.906 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -154.39 -53.66 0.1 Allowed 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.901 0.858 . . . . 3.8199999999999998 109.287 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 9.31 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.972 -1.467 . . . . 4.4699999999999998 109.833 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 mm? -79.19 118.55 73.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 119.587 -0.845 . . . . 3.7999999999999998 111.066 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 36' ' ' LEU . 72.8 Cg_exo -47.16 -150.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.128 2.552 . . . . 3.6099999999999999 112.992 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.891 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -143.25 -71.63 0.31 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.909 1.337 . . . . 3.0699999999999998 112.995 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 38' ' ' ASP . 96.9 mt -27.81 -62.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.53 -1.214 . . . . 2.6200000000000001 111.9 -178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.0 -27.51 22.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.95 -1.023 . . . . 2.2799999999999998 109.081 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 45' ' ' HIS . 29.5 m -82.72 -66.31 0.91 Allowed 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 114.073 -1.421 . . . . 2.1299999999999999 110.239 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.891 ' N ' ' O ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -50.53 -34.59 25.93 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.088 -1.045 . . . . 1.9399999999999999 109.936 -178.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -65.52 -63.5 1.08 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.693 -0.803 . . . . 2.7799999999999998 112.221 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 62.4 mt -86.19 -35.26 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.694 0.627 . . . . 1.3100000000000001 112.694 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 41' ' ' THR . 2.0 t60 -58.6 -43.56 89.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.95 -0.568 . . . . 1.5600000000000001 110.137 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 42' ' ' LEU . 21.0 m -63.62 -39.34 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 119.693 -0.803 . . . . 1.54 110.05 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.451 ' N ' HG23 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -51.79 -28.38 15.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 119.489 -0.884 . . . . 2.4500000000000002 109.958 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 1.2 p-10 -104.39 -34.5 8.26 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.933 -0.307 . . . . 2.2999999999999998 111.376 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 46' ' ' VAL . 42.6 m -94.85 -176.18 3.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.741 -0.837 . . . . 0.69999999999999996 108.741 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 50' ' ' ILE . 8.8 tp -100.41 87.08 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.299 0.571 . . . . 2.5099999999999998 110.018 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.168 -0.92 . . . . 2.29 110.034 -179.842 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.45 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 15.9 mt . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 108.42 -0.956 . . . . 4.8200000000000003 108.42 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 24' ' ' ILE . 98.8 Cg_exo -34.45 140.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 122.57 2.18 . . . . 3.77 112.143 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.533 ' O ' ' CG ' ' A' ' 27' ' ' HIS . 2.2 pp -121.33 117.98 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.792 -0.818 . . . . 2.9399999999999999 108.792 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 99.2 m-70 -158.69 130.72 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 3.7799999999999998 110.477 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -95.34 160.81 14.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.434 -0.58 . . . . 1.4299999999999999 109.434 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.476 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -66.49 175.54 1.31 Allowed Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 108.836 -0.801 . . . . 0.92000000000000004 108.836 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' GLY . 26.1 Cg_endo -83.41 -73.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.127 1.218 . . . . 1.3700000000000001 110.18 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.86 -44.9 65.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.845 -0.616 . . . . 4.29 110.879 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -46.56 52.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.192 0.52 . . . . 1.0 111.75 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . -114.66 -178.02 18.92 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 110.431 -1.067 . . . . 0.98999999999999999 110.431 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -174.12 -47.63 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.946 -0.761 . . . . 3.8199999999999998 108.946 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.2 10.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.739 -1.119 . . . . 4.4699999999999998 109.647 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.3 mt -115.73 73.41 4.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 113.232 0.827 . . . . 3.7999999999999998 113.232 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -87.53 117.17 1.19 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 123.146 2.564 . . . . 3.6099999999999999 110.986 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -85.45 -77.91 0.28 Allowed 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 118.015 -1.474 . . . . 3.0699999999999998 111.196 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.1 mt -154.45 -87.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.952 1.358 . . . . 2.6200000000000001 110.309 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.86 -24.77 13.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.261 -1.791 . . . . 2.2799999999999998 111.175 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -65.41 -44.01 88.77 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.734 -0.786 . . . . 2.1299999999999999 109.071 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.48 -41.14 61.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.858 -0.61 . . . . 1.9399999999999999 111.029 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.46 -41.05 89.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.508 -0.877 . . . . 2.7799999999999998 110.031 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.5 -42.2 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.235 0.541 . . . . 1.3100000000000001 110.572 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.67 -46.42 90.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 1.5600000000000001 111.55 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -32.82 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.319 -0.552 . . . . 1.54 110.987 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.15 -35.66 77.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.1 -0.5 . . . . 2.4500000000000002 109.874 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -92.73 -10.89 35.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.886 -0.412 . . . . 2.2999999999999998 109.886 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.11 -178.84 4.61 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.65 -0.871 . . . . 0.69999999999999996 108.65 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.414 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -109.78 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.911 0.386 . . . . 2.5099999999999998 110.503 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.414 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 96.0 mt . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.088 -0.958 . . . . 2.29 111.449 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.15 0.5 . . . . 2.94 110.969 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.632 ' ND1' HD12 ' A' ' 42' ' ' LEU . 62.9 t-80 -158.3 149.22 20.67 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.543 -0.753 . . . . 3.78 109.994 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -136.97 137.04 39.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.917 -0.772 . . . . 1.43 108.917 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -65.59 115.39 21.81 Favored Pre-proline 0 C--O 1.214 -0.795 0 N-CA-C 107.246 -1.39 . . . . 0.92 107.246 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.71 -41.63 14.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 120.533 1.226 . . . . 1.37 112.713 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.19 -44.52 79.45 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.783 0.66 . . . . 4.29 112.783 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 32.11 1.17 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.195 0.522 . . . . 1.0 111.298 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -76.22 120.39 5.86 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 109.903 -1.279 . . . . 0.99 109.903 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 10.7 mt-10 153.49 -37.96 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.663 -1.606 . . . . 3.82 106.663 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.93 -31.39 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 113.144 -1.843 . . . . 4.47 108.249 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -172.26 72.12 0.45 Allowed Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 117.945 -1.502 . . . . 3.8 111.814 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' CB ' ' O ' ' A' ' 27' ' ' HIS . 87.1 Cg_endo -88.29 67.28 3.21 Favored 'Trans proline' 0 C--N 1.291 -2.49 0 C-N-CA 122.008 1.805 . . . . 3.61 112.381 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 4.6 p-10 -88.02 -77.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.513 0.931 . . . . 3.07 113.513 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.444 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 41.5 mt -156.05 -77.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 122.404 1.097 . . . . 2.62 111.32 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -88.01 -34.43 18.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 112.962 -1.926 . . . . 2.28 111.965 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -61.15 -40.42 93.77 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.539 -0.911 . . . . 2.13 108.539 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -67.61 -42.1 82.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 1.94 109.758 179.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -57.77 -29.47 64.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.471 -0.892 . . . . 2.78 109.171 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.48 -38.82 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.234 0.54 . . . . 1.31 109.555 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.512 ' CE1' ' SG ' ' A' ' 49' ' ' CYS . 2.7 t60 -63.27 -48.73 76.94 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.677 -0.692 . . . . 1.56 111.605 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 49' ' ' CYS . 1.6 p -61.21 -32.81 53.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.269 -0.423 . . . . 1.54 110.655 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.9 ttp -61.85 -34.36 75.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.201 -0.454 . . . . 2.45 110.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 66.3 t0 -90.9 -23.74 20.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.443 -0.577 . . . . 2.3 109.443 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.527 ' C ' HD12 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -91.95 163.24 14.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.507 -0.923 . . . . 0.7 108.507 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.753 HD12 ' N ' ' A' ' 50' ' ' ILE . 1.9 mp -103.84 86.4 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.387 -0.597 . . . . 2.51 109.387 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 118.319 -0.848 . . . . 2.29 110.089 -179.52 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.403 ' CD1' ' OD1' ' A' ' 38' ' ' ASP . 44.2 mm . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 2.94 110.845 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -147.98 127.63 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.638 -0.71 . . . . 3.78 109.853 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.88 156.84 39.01 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.554 -0.748 . . . . 1.43 109.245 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.439 ' H ' HD12 ' A' ' 36' ' ' LEU . 24.6 m -72.77 155.76 90.5 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 108.949 -0.76 . . . . 0.92 108.949 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.7 -61.27 0.55 Allowed 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 119.857 0.985 . . . . 1.37 111.995 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -99.94 -18.95 16.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.207 0.447 . . . . 4.29 112.207 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -100.5 -10.75 20.75 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.739 0.304 . . . . 1.0 110.488 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.36 94.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.428 -0.891 . . . . 0.99 111.242 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -163.63 -45.5 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.921 -0.77 . . . . 3.82 108.921 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -103.56 3.6 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.298 -0.865 . . . . 4.47 110.36 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.631 ' CD1' ' HE2' ' A' ' 45' ' ' HIS . 16.0 mt -79.89 149.27 70.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 118.63 -1.228 . . . . 3.8 112.126 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 91.0 Cg_endo -76.33 -99.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.019 1.813 . . . . 3.61 112.86 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.844 ' O ' HD13 ' A' ' 39' ' ' ILE . 72.7 m-20 -143.38 -54.7 0.39 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.55 1.315 . . . . 3.07 114.55 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.844 HD13 ' O ' ' A' ' 38' ' ' ASP . 6.9 mm -143.01 -24.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.191 0.441 . . . . 2.62 112.191 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.78 -83.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.233 -0.439 . . . . 2.28 110.632 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -73.74 -4.35 33.97 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.348 -0.982 . . . . 2.13 108.348 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 42' ' ' LEU . 2.3 tm? -76.08 -55.37 5.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.299 -0.864 . . . . 1.94 110.146 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.453 ' N ' HD13 ' A' ' 42' ' ' LEU . 24.5 mt-30 -68.63 -39.12 80.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.444 -0.798 . . . . 2.78 111.873 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.84 -51.07 48.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.499 0.666 . . . . 1.31 112.014 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.631 ' HE2' ' CD1' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.81 -20.21 63.46 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.794 0.807 . . . . 1.56 110.636 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.619 ' N ' ' ND1' ' A' ' 45' ' ' HIS . 1.2 t -57.91 -43.88 85.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.035 -1.469 . . . . 1.54 107.035 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.3 mmm -59.74 -25.78 65.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.554 -1.276 . . . . 2.45 107.554 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.38 -24.75 20.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.784 -0.644 . . . . 2.3 111.536 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' HIS . 53.2 m -91.55 -176.0 4.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.014 -1.106 . . . . 0.7 108.014 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -108.73 80.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 2.51 110.206 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.918 -1.039 . . . . 2.29 110.456 179.654 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.7 pt . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.984 0.421 . . . . 2.94 110.982 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.453 ' HD2' HD12 ' A' ' 42' ' ' LEU . 75.9 t60 -149.26 140.69 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 3.78 110.315 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.625 ' HA ' HD11 ' A' ' 42' ' ' LEU . 5.7 p -134.11 151.13 51.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.668 -0.697 . . . . 1.43 109.357 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.647 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -67.87 115.89 32.61 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 108.081 -1.081 . . . . 0.92 108.081 177.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -47.26 -40.8 28.06 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 CA-C-N 120.684 1.28 . . . . 1.37 112.815 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.74 -49.18 60.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.639 0.978 . . . . 4.29 113.639 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.61 29.89 3.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.861 0.362 . . . . 1.0 110.535 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -99.26 133.78 11.43 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.314 -0.714 . . . . 0.99 111.314 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -168.79 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.518 -0.473 . . . . 3.82 110.406 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 m -124.66 9.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.815 -0.629 . . . . 4.47 109.86 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.7 mt -77.88 146.79 72.81 Favored Pre-proline 0 C--O 1.225 -0.213 0 C-N-CA 119.261 -0.976 . . . . 3.8 110.668 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.8 Cg_exo -36.95 -128.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.803 3.002 . . . . 3.61 114.52 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 93.1 m-20 -142.01 -39.71 0.37 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.268 0.47 . . . . 3.07 112.268 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.489 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 11.2 pt -146.68 -20.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 2.62 111.877 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -71.03 -74.84 0.14 Allowed 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 119.51 -0.876 . . . . 2.28 108.715 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 -14.09 59.65 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.027 -0.669 . . . . 2.13 109.416 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.637 ' O ' HG13 ' A' ' 46' ' ' VAL . 3.8 mm? -70.86 -42.92 69.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.228 0.537 . . . . 1.94 110.072 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 13.5 mm-40 -63.88 -33.6 76.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.625 -0.83 . . . . 2.78 108.918 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.5 mm -77.25 -40.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.116 -0.634 . . . . 1.31 110.74 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.474 ' ND1' ' CD1' ' A' ' 36' ' ' LEU . 15.3 t-160 -64.6 -46.98 80.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 1.56 111.041 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 42' ' ' LEU . 17.0 m -62.52 -29.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.736 -0.386 . . . . 1.54 110.865 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 67.5 mtp -61.76 -35.76 79.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.707 -0.397 . . . . 2.45 110.05 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 49' ' ' CYS . 3.3 p30 -94.08 -32.65 13.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.853 -0.339 . . . . 2.3 110.458 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 1.3 m -96.64 -174.73 3.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.946 -0.761 . . . . 0.7 108.946 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.13 101.86 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.892 -0.41 . . . . 2.51 109.892 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 51' ' ' ILE . 86.0 mt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.323 -0.846 . . . . 2.29 109.745 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 26' ' ' ILE . 8.9 tp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.078 0.466 . . . . 2.94 110.74 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -149.68 140.15 22.43 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.038 -0.528 . . . . 3.78 110.324 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -128.9 160.04 33.91 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.11 -0.496 . . . . 1.43 110.113 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' H ' HD22 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -67.49 166.5 21.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.442 -0.345 . . . . 0.92 110.106 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.47 -50.98 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.358 1.372 . . . . 1.37 111.267 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -109.52 -53.95 2.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.978 -1.01 . . . . 4.29 111.295 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 3.53 5.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.607 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.05 110.1 2.99 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.63 -0.795 . . . . 0.99 112.07 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -173.11 -49.8 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.193 -1.04 . . . . 3.82 108.193 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 9.54 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.213 -0.903 . . . . 4.47 109.965 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 29' ' ' CYS . 10.2 mp -75.9 131.49 76.15 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 119.079 -1.048 . . . . 3.8 110.883 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 36' ' ' LEU . 39.7 Cg_exo -42.56 -120.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.156 2.571 . . . . 3.61 113.748 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' OD1' HD12 ' A' ' 26' ' ' ILE . 99.7 m-20 -141.57 -47.88 0.38 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.138 0.494 . . . . 3.07 111.146 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 pt -144.31 -17.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.474 -0.785 . . . . 2.62 112.063 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.74 -81.37 0.06 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.67 -0.812 . . . . 2.28 109.279 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -79.71 -5.72 55.78 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.805 -0.758 . . . . 2.13 109.119 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.691 ' C ' HD13 ' A' ' 42' ' ' LEU . 2.9 tm? -73.92 -52.57 12.47 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.362 -0.535 . . . . 1.94 109.95 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -66.09 -31.69 72.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.822 -0.626 . . . . 2.78 110.583 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.12 -49.06 40.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.593 0.711 . . . . 1.31 110.584 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 49' ' ' CYS . 1.2 t60 -67.26 -44.6 78.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.539 -0.755 . . . . 1.56 111.818 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.16 -30.65 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.468 -0.493 . . . . 1.54 110.507 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.0 ttp -61.8 -33.85 74.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.49 -0.559 . . . . 2.45 109.49 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 67.7 t0 -89.47 -28.12 19.9 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.303 -0.628 . . . . 2.3 109.303 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 0.8 OUTLIER -90.89 -177.97 5.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.03 -0.729 . . . . 0.7 109.03 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.575 ' O ' HG23 ' A' ' 50' ' ' ILE . 14.9 tt -106.52 110.63 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.391 0.615 . . . . 2.51 109.805 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.056 -0.974 . . . . 2.29 110.869 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 120.892 0.377 . . . . 2.94 110.739 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -151.54 142.24 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 3.78 109.871 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 167.2 20.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.114 -0.494 . . . . 1.43 109.97 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.679 ' H ' HD12 ' A' ' 36' ' ' LEU . 90.5 m -72.23 159.77 84.51 Favored Pre-proline 0 N--CA 1.473 0.697 0 N-CA-C 108.33 -0.989 . . . . 0.92 108.33 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.19 -49.14 16.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.895 1.355 . . . . 1.37 112.738 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -113.25 -51.86 2.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.901 0.382 . . . . 4.29 110.129 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -62.94 -5.89 3.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.019 -0.537 . . . . 1.0 109.922 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.72 102.23 1.1 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.516 -0.849 . . . . 0.99 111.421 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.41 -50.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.637 -0.825 . . . . 3.82 110.564 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.83 12.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.468 -0.787 . . . . 4.47 109.898 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 29' ' ' CYS . 10.4 mt -73.67 150.84 88.96 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 118.687 -1.205 . . . . 3.8 111.381 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' A' ' 36' ' ' LEU . 77.5 Cg_exo -44.45 -126.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.042 2.494 . . . . 3.61 113.435 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 98.1 m-20 -139.87 -59.69 0.55 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.817 -0.552 . . . . 3.07 112.26 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 69.3 mt -145.66 -35.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.092 0.472 . . . . 2.62 112.034 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -66.28 -81.94 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.884 -0.726 . . . . 2.28 109.689 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.48 HG23 ' CG ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -73.31 -10.74 60.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.901 -0.591 . . . . 2.13 109.483 178.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.722 ' C ' HD13 ' A' ' 42' ' ' LEU . 2.8 tm? -73.43 -48.74 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.52 -0.472 . . . . 1.94 110.132 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 40.4 mm-40 -58.75 -39.04 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.54 -0.755 . . . . 2.78 109.065 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -71.32 -40.03 72.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.666 0.746 . . . . 1.31 109.858 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.412 ' CE1' ' SG ' ' A' ' 49' ' ' CYS . 1.3 t60 -61.8 -44.75 96.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.732 -0.667 . . . . 1.56 112.108 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -56.37 -33.84 39.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.411 -0.589 . . . . 1.54 109.411 -177.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 69.0 mtt -63.19 -28.75 70.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.839 -0.619 . . . . 2.45 109.602 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -87.27 -25.23 24.05 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.505 -0.478 . . . . 2.3 110.186 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 1.0 OUTLIER -93.08 -176.04 4.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.155 -0.683 . . . . 0.7 109.155 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 tt -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.575 0.703 . . . . 2.51 109.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 118.095 -0.955 . . . . 2.29 110.192 179.365 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 120.893 0.378 . . . . 2.94 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -141.86 142.15 33.1 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.123 -0.49 . . . . 3.78 109.789 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.35 158.32 44.71 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.086 -0.709 . . . . 1.43 109.086 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.447 ' N ' ' HA3' ' A' ' 33' ' ' GLY . 12.3 m -68.29 155.06 93.22 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 108.648 -0.871 . . . . 0.92 108.648 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -42.31 -62.62 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 CA-C-N 120.494 1.212 . . . . 1.37 112.543 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -102.27 -46.98 4.65 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.495 -0.32 . . . . 4.29 111.071 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.54 66.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.891 0.377 . . . . 1.0 110.06 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.447 ' HA3' ' N ' ' A' ' 29' ' ' CYS . . . -68.19 104.1 1.13 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.317 -0.944 . . . . 0.99 111.078 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -148.26 -46.33 0.16 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.658 0.742 . . . . 3.82 110.293 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.37 12.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.481 -1.236 . . . . 4.47 109.552 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 36' ' ' LEU . 3.6 mm? -74.97 152.12 86.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 118.781 -1.167 . . . . 3.8 110.365 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.5 Cg_exo -37.98 -137.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.998 3.132 . . . . 3.61 115.093 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 90.8 m-20 -139.29 -57.38 0.59 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.684 0.624 . . . . 3.07 112.684 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.1 pt -145.04 -34.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.269 0.47 . . . . 2.62 112.269 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.39 -75.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.527 0.68 . . . . 2.28 110.116 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.455 ' OG1' ' CG ' ' A' ' 37' ' ' PRO . 2.9 p -77.64 -7.13 55.96 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.922 -0.77 . . . . 2.13 108.922 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -76.77 -53.33 8.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.137 0.494 . . . . 1.94 111.04 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.08 -33.81 69.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.748 -0.834 . . . . 2.78 108.748 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mm -72.88 -42.22 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 119.708 -0.797 . . . . 1.31 109.585 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.641 ' CD2' HD12 ' A' ' 36' ' ' LEU . 3.7 t60 -65.06 -45.2 86.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.545 -0.752 . . . . 1.56 112.435 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -31.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.427 -0.509 . . . . 1.54 109.742 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 53.5 ttp -62.64 -31.72 72.63 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.762 -0.654 . . . . 2.45 109.406 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -88.36 -25.05 22.93 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.182 -0.463 . . . . 2.3 110.525 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.41 -176.49 4.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.553 -0.906 . . . . 0.7 108.553 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -107.38 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.479 . . . . 2.51 110.081 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 118.013 -0.994 . . . . 2.29 110.574 -179.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.505 ' O ' HD12 ' A' ' 26' ' ' ILE . 2.1 pp . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 121.166 0.508 . . . . 2.94 110.608 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.527 ' O ' HD22 ' A' ' 42' ' ' LEU . 78.8 m80 -158.77 139.95 13.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 3.78 110.223 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 34' ' ' GLU . 5.0 p -116.67 155.11 29.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.746 -0.465 . . . . 1.43 109.746 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -69.16 133.79 89.58 Favored Pre-proline 0 C--O 1.214 -0.781 0 N-CA-C 106.697 -1.594 . . . . 0.92 106.697 177.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -35.6 23.85 Favored 'Trans proline' 0 C--N 1.298 -2.122 0 CA-C-N 121.02 1.4 . . . . 1.37 113.388 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -63.48 -40.87 98.24 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.14 0.422 . . . . 4.29 112.14 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 -15.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.712 0.291 . . . . 1.0 111.471 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -91.43 150.81 20.61 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 110.157 -1.177 . . . . 0.99 110.157 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' ' OG ' ' A' ' 28' ' ' SER . 82.8 mt-10 -155.49 -46.46 0.08 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.562 0.696 . . . . 3.82 110.381 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.03 9.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.675 -1.148 . . . . 4.47 110.015 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 mt -108.27 84.06 2.13 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 119.887 -0.725 . . . . 3.8 112.405 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.35 128.51 8.07 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.282 1.988 . . . . 3.61 111.747 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 40' ' ' ASP . 6.0 m-20 -142.61 35.1 1.44 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 112.933 0.716 . . . . 3.07 112.933 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 40' ' ' ASP . 9.0 tp -9.4 -37.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 124.676 1.235 . . . . 2.62 113.548 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.817 ' N ' ' O ' ' A' ' 38' ' ' ASP . 64.5 t0 -76.73 -61.45 1.96 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.496 -1.298 . . . . 2.28 107.496 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.619 ' N ' ' O ' ' A' ' 38' ' ' ASP . 4.8 m -78.41 -23.18 46.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.897 -0.592 . . . . 2.13 110.266 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.527 HD22 ' O ' ' A' ' 27' ' ' HIS . 8.2 tp -71.16 -50.51 32.54 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 120.944 -0.302 . . . . 1.94 110.819 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.06 -24.88 64.93 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.92 -0.77 . . . . 2.78 108.92 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.05 -38.23 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.628 -0.714 . . . . 1.31 109.188 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.506 ' CE1' ' SG ' ' A' ' 49' ' ' CYS . 2.4 t60 -65.58 -47.42 75.83 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.913 -0.585 . . . . 1.56 111.007 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' CYS . 8.5 p -62.04 -31.51 51.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.418 . . . . 1.54 110.543 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.04 -34.16 74.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.761 -0.459 . . . . 2.45 109.761 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.83 -29.38 16.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 2.3 110.169 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.506 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 1.4 m -92.72 -179.67 5.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.176 -1.046 . . . . 0.7 108.176 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.413 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 47.8 mm -108.33 101.2 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.948 0.404 . . . . 2.51 110.422 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.413 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 20.3 tt . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.992 -1.004 . . . . 2.29 110.622 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 109.696 -0.483 . . . . 2.94 109.696 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -142.64 146.08 34.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.446 -0.576 . . . . 3.78 109.446 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.24 153.88 44.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.477 -0.328 . . . . 1.43 110.278 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -89.87 109.01 29.48 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 120.142 -0.623 . . . . 0.92 109.382 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' C ' ' O ' ' A' ' 29' ' ' CYS . 54.0 Cg_exo -37.02 -29.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 CA-C-N 121.076 1.42 . . . . 1.37 112.265 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' CYS . 52.7 tptt -65.24 -45.21 85.51 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.142 -0.481 . . . . 4.29 111.394 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.467 ' O ' HD11 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -149.85 14.37 0.83 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.796 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -59.47 111.91 3.84 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.889 -0.596 . . . . 0.99 111.927 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -155.67 -52.29 0.09 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.66 0.743 . . . . 3.82 110.991 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.21 11.37 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.599 -1.182 . . . . 4.47 111.16 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.927 ' H ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.06 157.97 82.7 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 119.118 -1.033 . . . . 3.8 110.917 -178.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -22.97 -134.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 125.191 3.927 . . . . 3.61 115.332 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 85.4 m-20 -143.31 -59.19 0.42 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.19 0.811 . . . . 3.07 113.19 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -144.32 -41.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.226 0.454 . . . . 2.62 112.226 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.71 -74.26 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.263 -0.575 . . . . 2.28 110.463 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.9 m -69.39 -17.49 63.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.161 -0.681 . . . . 2.13 109.161 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -68.73 -49.48 58.45 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.783 -0.644 . . . . 1.94 110.024 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -54.98 -33.16 62.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.335 -0.987 . . . . 2.78 108.335 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.0 -31.28 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.086 -0.645 . . . . 1.31 109.713 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -66.51 -47.2 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 1.56 111.508 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -59.37 -33.53 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.905 -0.718 . . . . 1.54 109.876 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -31.25 71.49 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.863 -0.608 . . . . 2.45 109.746 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.04 -23.83 21.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.715 0.293 . . . . 2.3 110.223 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -178.67 5.14 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.035 -0.728 . . . . 0.7 109.035 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -110.57 92.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.032 -0.359 . . . . 2.51 110.032 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.971 -1.014 . . . . 2.29 110.71 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.0 tt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.928 0.394 . . . . 2.94 111.714 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.538 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 p-80 -77.22 86.76 3.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.735 -0.666 . . . . 3.78 112.096 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.697 ' O ' HD21 ' A' ' 42' ' ' LEU . 13.2 p -156.79 162.31 39.74 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 121.721 0.772 . . . . 1.43 111.802 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -153.09 115.95 2.77 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 106.297 -1.742 . . . . 0.92 106.297 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -47.08 -41.27 26.72 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 121.448 1.553 . . . . 1.37 112.534 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HG2' HG22 ' A' ' 50' ' ' ILE . 70.0 mmtt -67.3 -42.51 83.61 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.094 0.776 . . . . 4.29 113.094 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -138.83 33.26 2.2 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 1.0 110.203 -177.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -74.94 100.52 1.23 Allowed Glycine 0 C--O 1.23 -0.123 0 CA-C-N 115.714 -0.675 . . . . 0.99 111.906 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -154.39 -53.66 0.1 Allowed 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.901 0.858 . . . . 3.82 109.287 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 9.31 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.972 -1.467 . . . . 4.47 109.833 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 mm? -79.19 118.55 73.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 119.587 -0.845 . . . . 3.8 111.066 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 36' ' ' LEU . 72.8 Cg_exo -47.16 -150.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.128 2.552 . . . . 3.61 112.992 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.891 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -143.25 -71.63 0.31 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.909 1.337 . . . . 3.07 112.995 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 38' ' ' ASP . 96.9 mt -27.81 -62.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.53 -1.214 . . . . 2.62 111.9 -178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.0 -27.51 22.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.95 -1.023 . . . . 2.28 109.081 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 45' ' ' HIS . 29.5 m -82.72 -66.31 0.91 Allowed 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 114.073 -1.421 . . . . 2.13 110.239 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.891 ' N ' ' O ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -50.53 -34.59 25.93 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.088 -1.045 . . . . 1.94 109.936 -178.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -65.52 -63.5 1.08 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.693 -0.803 . . . . 2.78 112.221 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 62.4 mt -86.19 -35.26 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.694 0.627 . . . . 1.31 112.694 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 41' ' ' THR . 2.0 t60 -58.6 -43.56 89.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.95 -0.568 . . . . 1.56 110.137 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 42' ' ' LEU . 21.0 m -63.62 -39.34 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 119.693 -0.803 . . . . 1.54 110.05 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.451 ' N ' HG23 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -51.79 -28.38 15.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 119.489 -0.884 . . . . 2.45 109.958 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 1.2 p-10 -104.39 -34.5 8.26 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.933 -0.307 . . . . 2.3 111.376 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.498 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 42.6 m -94.85 -176.18 3.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.741 -0.837 . . . . 0.7 108.741 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.75 ' O ' HG23 ' A' ' 50' ' ' ILE . 8.8 tp -100.41 87.08 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.299 0.571 . . . . 2.51 110.018 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.168 -0.92 . . . . 2.29 110.034 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.533 ' O ' ' CG ' ' A' ' 27' ' ' HIS . 2.2 pp . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 108.792 -0.818 . . . . 2.94 108.792 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 99.2 m-70 -158.69 130.72 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 3.78 110.477 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -95.34 160.81 14.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.434 -0.58 . . . . 1.43 109.434 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.476 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -66.49 175.54 1.31 Allowed Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 108.836 -0.801 . . . . 0.92 108.836 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' GLY . 26.1 Cg_endo -83.41 -73.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.127 1.218 . . . . 1.37 110.18 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.86 -44.9 65.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.845 -0.616 . . . . 4.29 110.879 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -46.56 52.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.192 0.52 . . . . 1.0 111.75 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . -114.66 -178.02 18.92 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 110.431 -1.067 . . . . 0.99 110.431 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -174.12 -47.63 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.946 -0.761 . . . . 3.82 108.946 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.2 10.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.739 -1.119 . . . . 4.47 109.647 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.3 mt -115.73 73.41 4.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 113.232 0.827 . . . . 3.8 113.232 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -87.53 117.17 1.19 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 123.146 2.564 . . . . 3.61 110.986 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -85.45 -77.91 0.28 Allowed 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 118.015 -1.474 . . . . 3.07 111.196 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.1 mt -154.45 -87.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.952 1.358 . . . . 2.62 110.309 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.86 -24.77 13.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.261 -1.791 . . . . 2.28 111.175 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -65.41 -44.01 88.77 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.734 -0.786 . . . . 2.13 109.071 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.48 -41.14 61.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.858 -0.61 . . . . 1.94 111.029 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.46 -41.05 89.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.508 -0.877 . . . . 2.78 110.031 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.5 -42.2 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.235 0.541 . . . . 1.31 110.572 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.412 ' CE1' ' SG ' ' A' ' 49' ' ' CYS . 1.4 t60 -60.67 -46.42 90.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 1.56 111.55 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -32.82 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.319 -0.552 . . . . 1.54 110.987 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.15 -35.66 77.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.1 -0.5 . . . . 2.45 109.874 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -92.73 -10.89 35.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.886 -0.412 . . . . 2.3 109.886 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' SG ' ' CE1' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -95.11 -178.84 4.61 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.65 -0.871 . . . . 0.7 108.65 178.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.414 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -109.78 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.911 0.386 . . . . 2.51 110.503 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.414 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 96.0 mt . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.088 -0.958 . . . . 2.29 111.449 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.601 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 110.1 -0.333 . . . . 4.82 110.1 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 24' ' ' ILE . 83.0 Cg_endo -88.49 -177.32 1.73 Allowed 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.442 2.095 . . . . 3.77 111.941 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 pt -124.83 160.26 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.15 0.5 . . . . 2.94 110.969 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.632 ' ND1' HD12 ' A' ' 42' ' ' LEU . 62.9 t-80 -158.3 149.22 20.67 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.543 -0.753 . . . . 3.78 109.994 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -136.97 137.04 39.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.917 -0.772 . . . . 1.43 108.917 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -65.59 115.39 21.81 Favored Pre-proline 0 C--O 1.214 -0.795 0 N-CA-C 107.246 -1.39 . . . . 0.92 107.246 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.71 -41.63 14.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 120.533 1.226 . . . . 1.37 112.713 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.19 -44.52 79.45 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.783 0.66 . . . . 4.29 112.783 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 32.11 1.17 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.195 0.522 . . . . 1.0 111.298 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -76.22 120.39 5.86 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 109.903 -1.279 . . . . 0.99 109.903 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 10.7 mt-10 153.49 -37.96 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.663 -1.606 . . . . 3.82 106.663 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.93 -31.39 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 113.144 -1.843 . . . . 4.47 108.249 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -172.26 72.12 0.45 Allowed Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 117.945 -1.502 . . . . 3.8 111.814 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' CB ' ' O ' ' A' ' 27' ' ' HIS . 87.1 Cg_endo -88.29 67.28 3.21 Favored 'Trans proline' 0 C--N 1.291 -2.49 0 C-N-CA 122.008 1.805 . . . . 3.61 112.381 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 4.6 p-10 -88.02 -77.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.513 0.931 . . . . 3.07 113.513 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.444 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 41.5 mt -156.05 -77.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 122.404 1.097 . . . . 2.62 111.32 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -88.01 -34.43 18.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 112.962 -1.926 . . . . 2.28 111.965 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -61.15 -40.42 93.77 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.539 -0.911 . . . . 2.13 108.539 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -67.61 -42.1 82.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 1.94 109.758 179.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -57.77 -29.47 64.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.471 -0.892 . . . . 2.78 109.171 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.48 -38.82 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.234 0.54 . . . . 1.31 109.555 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -63.27 -48.73 76.94 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.677 -0.692 . . . . 1.56 111.605 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 49' ' ' CYS . 1.6 p -61.21 -32.81 53.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.269 -0.423 . . . . 1.54 110.655 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.9 ttp -61.85 -34.36 75.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.201 -0.454 . . . . 2.45 110.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 66.3 t0 -90.9 -23.74 20.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.443 -0.577 . . . . 2.3 109.443 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.527 ' C ' HD12 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -91.95 163.24 14.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.507 -0.923 . . . . 0.7 108.507 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.753 HD12 ' N ' ' A' ' 50' ' ' ILE . 1.9 mp -103.84 86.4 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.387 -0.597 . . . . 2.51 109.387 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 118.319 -0.848 . . . . 2.29 110.089 -179.52 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 108.412 -0.958 . . . . 4.82 108.412 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.84 145.93 97.0 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.527 1.485 . . . . 3.77 111.64 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.403 ' CD1' ' OD1' ' A' ' 38' ' ' ASP . 44.2 mm -112.75 129.85 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 2.94 110.845 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -147.98 127.63 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.638 -0.71 . . . . 3.78 109.853 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.88 156.84 39.01 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.554 -0.748 . . . . 1.43 109.245 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.439 ' H ' HD12 ' A' ' 36' ' ' LEU . 24.6 m -72.77 155.76 90.5 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 108.949 -0.76 . . . . 0.92 108.949 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.7 -61.27 0.55 Allowed 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 119.857 0.985 . . . . 1.37 111.995 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -99.94 -18.95 16.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.207 0.447 . . . . 4.29 112.207 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -100.5 -10.75 20.75 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.739 0.304 . . . . 1.0 110.488 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.36 94.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.428 -0.891 . . . . 0.99 111.242 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -163.63 -45.5 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.921 -0.77 . . . . 3.82 108.921 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -103.56 3.6 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.298 -0.865 . . . . 4.47 110.36 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.631 ' CD1' ' HE2' ' A' ' 45' ' ' HIS . 16.0 mt -79.89 149.27 70.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 118.63 -1.228 . . . . 3.8 112.126 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 91.0 Cg_endo -76.33 -99.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.019 1.813 . . . . 3.61 112.86 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.844 ' O ' HD13 ' A' ' 39' ' ' ILE . 72.7 m-20 -143.38 -54.7 0.39 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.55 1.315 . . . . 3.07 114.55 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.844 HD13 ' O ' ' A' ' 38' ' ' ASP . 6.9 mm -143.01 -24.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.191 0.441 . . . . 2.62 112.191 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.78 -83.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.233 -0.439 . . . . 2.28 110.632 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -73.74 -4.35 33.97 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.348 -0.982 . . . . 2.13 108.348 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 42' ' ' LEU . 2.3 tm? -76.08 -55.37 5.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.299 -0.864 . . . . 1.94 110.146 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.453 ' N ' HD13 ' A' ' 42' ' ' LEU . 24.5 mt-30 -68.63 -39.12 80.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.444 -0.798 . . . . 2.78 111.873 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.84 -51.07 48.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.499 0.666 . . . . 1.31 112.014 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.631 ' HE2' ' CD1' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.81 -20.21 63.46 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.794 0.807 . . . . 1.56 110.636 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.619 ' N ' ' ND1' ' A' ' 45' ' ' HIS . 1.2 t -57.91 -43.88 85.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.035 -1.469 . . . . 1.54 107.035 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.3 mmm -59.74 -25.78 65.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.554 -1.276 . . . . 2.45 107.554 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.38 -24.75 20.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.784 -0.644 . . . . 2.3 111.536 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' HIS . 53.2 m -91.55 -176.0 4.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.014 -1.106 . . . . 0.7 108.014 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -108.73 80.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 2.51 110.206 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.918 -1.039 . . . . 2.29 110.456 179.654 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 24' ' ' ILE . 16.3 mt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.098 -0.704 . . . . 4.82 109.098 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.04 156.2 47.43 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.738 2.292 . . . . 3.77 112.196 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.7 pt -77.4 166.92 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 2.94 110.982 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.453 ' HD2' HD12 ' A' ' 42' ' ' LEU . 75.9 t60 -149.26 140.69 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 3.78 110.315 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.625 ' HA ' HD11 ' A' ' 42' ' ' LEU . 5.7 p -134.11 151.13 51.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.668 -0.697 . . . . 1.43 109.357 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.647 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -67.87 115.89 32.61 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 108.081 -1.081 . . . . 0.92 108.081 177.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -47.26 -40.8 28.06 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 CA-C-N 120.684 1.28 . . . . 1.37 112.815 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.74 -49.18 60.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.639 0.978 . . . . 4.29 113.639 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.61 29.89 3.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.861 0.362 . . . . 1.0 110.535 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -99.26 133.78 11.43 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.314 -0.714 . . . . 0.99 111.314 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -168.79 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.518 -0.473 . . . . 3.82 110.406 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 m -124.66 9.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.815 -0.629 . . . . 4.47 109.86 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.7 mt -77.88 146.79 72.81 Favored Pre-proline 0 C--O 1.225 -0.213 0 C-N-CA 119.261 -0.976 . . . . 3.8 110.668 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.8 Cg_exo -36.95 -128.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.803 3.002 . . . . 3.61 114.52 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 93.1 m-20 -142.01 -39.71 0.37 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.268 0.47 . . . . 3.07 112.268 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.489 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 11.2 pt -146.68 -20.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 2.62 111.877 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -71.03 -74.84 0.14 Allowed 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 119.51 -0.876 . . . . 2.28 108.715 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 -14.09 59.65 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.027 -0.669 . . . . 2.13 109.416 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.637 ' O ' HG13 ' A' ' 46' ' ' VAL . 3.8 mm? -70.86 -42.92 69.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.228 0.537 . . . . 1.94 110.072 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 13.5 mm-40 -63.88 -33.6 76.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.625 -0.83 . . . . 2.78 108.918 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.5 mm -77.25 -40.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.116 -0.634 . . . . 1.31 110.74 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.474 ' ND1' ' CD1' ' A' ' 36' ' ' LEU . 15.3 t-160 -64.6 -46.98 80.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 1.56 111.041 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 42' ' ' LEU . 17.0 m -62.52 -29.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.736 -0.386 . . . . 1.54 110.865 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 67.5 mtp -61.76 -35.76 79.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.707 -0.397 . . . . 2.45 110.05 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 49' ' ' CYS . 3.3 p30 -94.08 -32.65 13.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.853 -0.339 . . . . 2.3 110.458 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 1.3 m -96.64 -174.73 3.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.946 -0.761 . . . . 0.7 108.946 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.13 101.86 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.892 -0.41 . . . . 2.51 109.892 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 51' ' ' ILE . 86.0 mt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.323 -0.846 . . . . 2.29 109.745 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.5 mm . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.158 -0.682 . . . . 4.82 109.158 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.88 143.86 37.6 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.44 2.093 . . . . 3.77 111.862 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 26' ' ' ILE . 8.9 tp -91.48 127.63 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 121.078 0.466 . . . . 2.94 110.74 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -149.68 140.15 22.43 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.038 -0.528 . . . . 3.78 110.324 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -128.9 160.04 33.91 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.11 -0.496 . . . . 1.43 110.113 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' H ' HD22 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -67.49 166.5 21.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.442 -0.345 . . . . 0.92 110.106 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.47 -50.98 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.358 1.372 . . . . 1.37 111.267 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -109.52 -53.95 2.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.978 -1.01 . . . . 4.29 111.295 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 3.53 5.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.607 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.05 110.1 2.99 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.63 -0.795 . . . . 0.99 112.07 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -173.11 -49.8 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.193 -1.04 . . . . 3.82 108.193 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 9.54 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.213 -0.903 . . . . 4.47 109.965 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 29' ' ' CYS . 10.2 mp -75.9 131.49 76.15 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 119.079 -1.048 . . . . 3.8 110.883 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 36' ' ' LEU . 39.7 Cg_exo -42.56 -120.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.156 2.571 . . . . 3.61 113.748 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' OD1' HD12 ' A' ' 26' ' ' ILE . 99.7 m-20 -141.57 -47.88 0.38 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.138 0.494 . . . . 3.07 111.146 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 pt -144.31 -17.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.474 -0.785 . . . . 2.62 112.063 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.74 -81.37 0.06 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.67 -0.812 . . . . 2.28 109.279 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -79.71 -5.72 55.78 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.805 -0.758 . . . . 2.13 109.119 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.691 ' C ' HD13 ' A' ' 42' ' ' LEU . 2.9 tm? -73.92 -52.57 12.47 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.362 -0.535 . . . . 1.94 109.95 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -66.09 -31.69 72.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.822 -0.626 . . . . 2.78 110.583 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.12 -49.06 40.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.593 0.711 . . . . 1.31 110.584 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -67.26 -44.6 78.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.539 -0.755 . . . . 1.56 111.818 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.16 -30.65 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.468 -0.493 . . . . 1.54 110.507 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.0 ttp -61.8 -33.85 74.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.49 -0.559 . . . . 2.45 109.49 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 67.7 t0 -89.47 -28.12 19.9 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.303 -0.628 . . . . 2.3 109.303 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.89 -177.97 5.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.03 -0.729 . . . . 0.7 109.03 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.575 ' O ' HG23 ' A' ' 50' ' ' ILE . 14.9 tt -106.52 110.63 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.391 0.615 . . . . 2.51 109.805 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.056 -0.974 . . . . 2.29 110.869 -179.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.564 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 mp . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 110.236 -0.283 . . . . 4.82 110.236 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 24' ' ' ILE . 91.3 Cg_endo -85.06 155.53 11.23 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.389 1.393 . . . . 3.77 112.308 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 pt -131.15 166.04 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.787 -0.642 . . . . 2.94 110.739 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -151.54 142.24 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 3.78 109.871 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 167.2 20.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.114 -0.494 . . . . 1.43 109.97 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.679 ' H ' HD12 ' A' ' 36' ' ' LEU . 90.5 m -72.23 159.77 84.51 Favored Pre-proline 0 N--CA 1.473 0.697 0 N-CA-C 108.33 -0.989 . . . . 0.92 108.33 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.19 -49.14 16.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.895 1.355 . . . . 1.37 112.738 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -113.25 -51.86 2.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.901 0.382 . . . . 4.29 110.129 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -62.94 -5.89 3.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.019 -0.537 . . . . 1.0 109.922 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.72 102.23 1.1 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.516 -0.849 . . . . 0.99 111.421 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.41 -50.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.637 -0.825 . . . . 3.82 110.564 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.83 12.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.468 -0.787 . . . . 4.47 109.898 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 29' ' ' CYS . 10.4 mt -73.67 150.84 88.96 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 118.687 -1.205 . . . . 3.8 111.381 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' A' ' 36' ' ' LEU . 77.5 Cg_exo -44.45 -126.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.042 2.494 . . . . 3.61 113.435 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 98.1 m-20 -139.87 -59.69 0.55 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.817 -0.552 . . . . 3.07 112.26 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 69.3 mt -145.66 -35.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.092 0.472 . . . . 2.62 112.034 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -66.28 -81.94 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.884 -0.726 . . . . 2.28 109.689 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.48 HG23 ' CG ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -73.31 -10.74 60.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.901 -0.591 . . . . 2.13 109.483 178.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.722 ' C ' HD13 ' A' ' 42' ' ' LEU . 2.8 tm? -73.43 -48.74 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.52 -0.472 . . . . 1.94 110.132 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 39' ' ' ILE . 40.4 mm-40 -58.75 -39.04 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.54 -0.755 . . . . 2.78 109.065 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -71.32 -40.03 72.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.666 0.746 . . . . 1.31 109.858 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.404 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 1.3 t60 -61.8 -44.75 96.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.732 -0.667 . . . . 1.56 112.108 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -56.37 -33.84 39.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.411 -0.589 . . . . 1.54 109.411 -177.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 69.0 mtt -63.19 -28.75 70.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.839 -0.619 . . . . 2.45 109.602 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -87.27 -25.23 24.05 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.505 -0.478 . . . . 2.3 110.186 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -93.08 -176.04 4.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.155 -0.683 . . . . 0.7 109.155 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 tt -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.575 0.703 . . . . 2.51 109.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 118.095 -0.955 . . . . 2.29 110.192 179.365 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 25' ' ' PRO . 9.1 tt . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 108.099 -1.075 . . . . 4.82 108.099 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 24' ' ' ILE . 17.4 Cg_exo -29.72 123.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.69 2.26 . . . . 3.77 113.952 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.0 tt -130.06 139.81 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.09 -0.959 . . . . 2.94 110.543 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -141.86 142.15 33.1 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.123 -0.49 . . . . 3.78 109.789 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.35 158.32 44.71 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.086 -0.709 . . . . 1.43 109.086 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.447 ' N ' ' HA3' ' A' ' 33' ' ' GLY . 12.3 m -68.29 155.06 93.22 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 108.648 -0.871 . . . . 0.92 108.648 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -42.31 -62.62 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 CA-C-N 120.494 1.212 . . . . 1.37 112.543 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -102.27 -46.98 4.65 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.495 -0.32 . . . . 4.29 111.071 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.54 66.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.891 0.377 . . . . 1.0 110.06 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.447 ' HA3' ' N ' ' A' ' 29' ' ' CYS . . . -68.19 104.1 1.13 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.317 -0.944 . . . . 0.99 111.078 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -148.26 -46.33 0.16 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.658 0.742 . . . . 3.82 110.293 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.37 12.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.481 -1.236 . . . . 4.47 109.552 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 36' ' ' LEU . 3.6 mm? -74.97 152.12 86.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 118.781 -1.167 . . . . 3.8 110.365 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 36' ' ' LEU . 86.5 Cg_exo -37.98 -137.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.998 3.132 . . . . 3.61 115.093 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 90.8 m-20 -139.29 -57.38 0.59 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.684 0.624 . . . . 3.07 112.684 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.1 pt -145.04 -34.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.269 0.47 . . . . 2.62 112.269 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.39 -75.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.527 0.68 . . . . 2.28 110.116 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.455 ' OG1' ' CG ' ' A' ' 37' ' ' PRO . 2.9 p -77.64 -7.13 55.96 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.922 -0.77 . . . . 2.13 108.922 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -76.77 -53.33 8.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.137 0.494 . . . . 1.94 111.04 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.08 -33.81 69.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.748 -0.834 . . . . 2.78 108.748 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mm -72.88 -42.22 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 119.708 -0.797 . . . . 1.31 109.585 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.641 ' CD2' HD12 ' A' ' 36' ' ' LEU . 3.7 t60 -65.06 -45.2 86.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.545 -0.752 . . . . 1.56 112.435 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -31.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.427 -0.509 . . . . 1.54 109.742 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 53.5 ttp -62.64 -31.72 72.63 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.762 -0.654 . . . . 2.45 109.406 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -88.36 -25.05 22.93 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.182 -0.463 . . . . 2.3 110.525 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.41 -176.49 4.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.553 -0.906 . . . . 0.7 108.553 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -107.38 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.479 . . . . 2.51 110.081 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 118.013 -0.994 . . . . 2.29 110.574 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.647 -0.871 . . . . 4.82 108.647 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.25 151.72 66.42 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.36 2.04 . . . . 3.77 111.969 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.505 ' O ' HD12 ' A' ' 26' ' ' ILE . 2.1 pp -118.23 115.77 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.166 0.508 . . . . 2.94 110.608 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.527 ' O ' HD22 ' A' ' 42' ' ' LEU . 78.8 m80 -158.77 139.95 13.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 3.78 110.223 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 34' ' ' GLU . 5.0 p -116.67 155.11 29.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.746 -0.465 . . . . 1.43 109.746 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -69.16 133.79 89.58 Favored Pre-proline 0 C--O 1.214 -0.781 0 N-CA-C 106.697 -1.594 . . . . 0.92 106.697 177.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -35.6 23.85 Favored 'Trans proline' 0 C--N 1.298 -2.122 0 CA-C-N 121.02 1.4 . . . . 1.37 113.388 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -63.48 -40.87 98.24 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.14 0.422 . . . . 4.29 112.14 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 -15.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.712 0.291 . . . . 1.0 111.471 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -91.43 150.81 20.61 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 110.157 -1.177 . . . . 0.99 110.157 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' ' OG ' ' A' ' 28' ' ' SER . 82.8 mt-10 -155.49 -46.46 0.08 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.562 0.696 . . . . 3.82 110.381 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.03 9.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.675 -1.148 . . . . 4.47 110.015 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 mt -108.27 84.06 2.13 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 119.887 -0.725 . . . . 3.8 112.405 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.35 128.51 8.07 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.282 1.988 . . . . 3.61 111.747 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 40' ' ' ASP . 6.0 m-20 -142.61 35.1 1.44 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 112.933 0.716 . . . . 3.07 112.933 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 40' ' ' ASP . 9.0 tp -9.4 -37.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 124.676 1.235 . . . . 2.62 113.548 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.817 ' N ' ' O ' ' A' ' 38' ' ' ASP . 64.5 t0 -76.73 -61.45 1.96 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.496 -1.298 . . . . 2.28 107.496 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.619 ' N ' ' O ' ' A' ' 38' ' ' ASP . 4.8 m -78.41 -23.18 46.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.897 -0.592 . . . . 2.13 110.266 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.527 HD22 ' O ' ' A' ' 27' ' ' HIS . 8.2 tp -71.16 -50.51 32.54 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 120.944 -0.302 . . . . 1.94 110.819 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.06 -24.88 64.93 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.92 -0.77 . . . . 2.78 108.92 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.05 -38.23 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.628 -0.714 . . . . 1.31 109.188 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -65.58 -47.42 75.83 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.913 -0.585 . . . . 1.56 111.007 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' CYS . 8.5 p -62.04 -31.51 51.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.418 . . . . 1.54 110.543 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.04 -34.16 74.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.761 -0.459 . . . . 2.45 109.761 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.83 -29.38 16.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 2.3 110.169 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 46' ' ' VAL . 1.4 m -92.72 -179.67 5.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.176 -1.046 . . . . 0.7 108.176 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.413 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 47.8 mm -108.33 101.2 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.948 0.404 . . . . 2.51 110.422 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.413 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 20.3 tt . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.992 -1.004 . . . . 2.29 110.622 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 mm . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.577 -0.527 . . . . 4.82 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.34 125.08 16.04 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 121.669 1.579 . . . . 3.77 112.528 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.3 pt -140.88 163.2 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.696 -0.483 . . . . 2.94 109.696 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -142.64 146.08 34.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.446 -0.576 . . . . 3.78 109.446 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.24 153.88 44.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.477 -0.328 . . . . 1.43 110.278 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -89.87 109.01 29.48 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 120.142 -0.623 . . . . 0.92 109.382 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' C ' ' O ' ' A' ' 29' ' ' CYS . 54.0 Cg_exo -37.02 -29.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 CA-C-N 121.076 1.42 . . . . 1.37 112.265 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' CYS . 52.7 tptt -65.24 -45.21 85.51 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.142 -0.481 . . . . 4.29 111.394 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.467 ' O ' HD11 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -149.85 14.37 0.83 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.796 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -59.47 111.91 3.84 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.889 -0.596 . . . . 0.99 111.927 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -155.67 -52.29 0.09 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.66 0.743 . . . . 3.82 110.991 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.21 11.37 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.599 -1.182 . . . . 4.47 111.16 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.927 ' H ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.06 157.97 82.7 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 119.118 -1.033 . . . . 3.8 110.917 -178.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -22.97 -134.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 125.191 3.927 . . . . 3.61 115.332 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 37' ' ' PRO . 85.4 m-20 -143.31 -59.19 0.42 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.19 0.811 . . . . 3.07 113.19 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -144.32 -41.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.226 0.454 . . . . 2.62 112.226 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.71 -74.26 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.263 -0.575 . . . . 2.28 110.463 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.9 m -69.39 -17.49 63.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.161 -0.681 . . . . 2.13 109.161 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -68.73 -49.48 58.45 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.783 -0.644 . . . . 1.94 110.024 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -54.98 -33.16 62.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.335 -0.987 . . . . 2.78 108.335 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.0 -31.28 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.086 -0.645 . . . . 1.31 109.713 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -66.51 -47.2 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 1.56 111.508 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -59.37 -33.53 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.905 -0.718 . . . . 1.54 109.876 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -31.25 71.49 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.863 -0.608 . . . . 2.45 109.746 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.04 -23.83 21.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.715 0.293 . . . . 2.3 110.223 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -178.67 5.14 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.035 -0.728 . . . . 0.7 109.035 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -110.57 92.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.032 -0.359 . . . . 2.51 110.032 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.971 -1.014 . . . . 2.29 110.71 -179.987 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.4 mp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.438 -0.578 . . . . 4.82 109.438 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.31 172.01 11.87 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.94 2.426 . . . . 3.77 111.433 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.0 tt -61.18 160.07 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.928 0.394 . . . . 2.94 111.714 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.538 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 p-80 -77.22 86.76 3.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.735 -0.666 . . . . 3.78 112.096 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.697 ' O ' HD21 ' A' ' 42' ' ' LEU . 13.2 p -156.79 162.31 39.74 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 121.721 0.772 . . . . 1.43 111.802 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -153.09 115.95 2.77 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 106.297 -1.742 . . . . 0.92 106.297 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -47.08 -41.27 26.72 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 121.448 1.553 . . . . 1.37 112.534 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HG2' HG22 ' A' ' 50' ' ' ILE . 70.0 mmtt -67.3 -42.51 83.61 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.094 0.776 . . . . 4.29 113.094 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -138.83 33.26 2.2 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 1.0 110.203 -177.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -74.94 100.52 1.23 Allowed Glycine 0 C--O 1.23 -0.123 0 CA-C-N 115.714 -0.675 . . . . 0.99 111.906 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -154.39 -53.66 0.1 Allowed 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.901 0.858 . . . . 3.82 109.287 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 9.31 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.972 -1.467 . . . . 4.47 109.833 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 mm? -79.19 118.55 73.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 119.587 -0.845 . . . . 3.8 111.066 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 36' ' ' LEU . 72.8 Cg_exo -47.16 -150.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.128 2.552 . . . . 3.61 112.992 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.891 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -143.25 -71.63 0.31 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.909 1.337 . . . . 3.07 112.995 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 38' ' ' ASP . 96.9 mt -27.81 -62.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.53 -1.214 . . . . 2.62 111.9 -178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.0 -27.51 22.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.95 -1.023 . . . . 2.28 109.081 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 45' ' ' HIS . 29.5 m -82.72 -66.31 0.91 Allowed 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 114.073 -1.421 . . . . 2.13 110.239 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.891 ' N ' ' O ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -50.53 -34.59 25.93 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.088 -1.045 . . . . 1.94 109.936 -178.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -65.52 -63.5 1.08 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.693 -0.803 . . . . 2.78 112.221 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 62.4 mt -86.19 -35.26 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.694 0.627 . . . . 1.31 112.694 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 41' ' ' THR . 2.0 t60 -58.6 -43.56 89.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.95 -0.568 . . . . 1.56 110.137 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 42' ' ' LEU . 21.0 m -63.62 -39.34 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 119.693 -0.803 . . . . 1.54 110.05 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.451 ' N ' HG23 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -51.79 -28.38 15.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 119.489 -0.884 . . . . 2.45 109.958 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 1.2 p-10 -104.39 -34.5 8.26 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.933 -0.307 . . . . 2.3 111.376 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 46' ' ' VAL . 42.6 m -94.85 -176.18 3.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.741 -0.837 . . . . 0.7 108.741 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.75 ' O ' HG23 ' A' ' 50' ' ' ILE . 8.8 tp -100.41 87.08 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.299 0.571 . . . . 2.51 110.018 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.168 -0.92 . . . . 2.29 110.034 -179.842 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.45 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 15.9 mt . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 108.42 -0.956 . . . . 4.82 108.42 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 24' ' ' ILE . 98.8 Cg_exo -34.45 140.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 122.57 2.18 . . . . 3.77 112.143 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.533 ' O ' ' CG ' ' A' ' 27' ' ' HIS . 2.2 pp -121.33 117.98 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.792 -0.818 . . . . 2.94 108.792 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 99.2 m-70 -158.69 130.72 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 3.78 110.477 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -95.34 160.81 14.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.434 -0.58 . . . . 1.43 109.434 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.476 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -66.49 175.54 1.31 Allowed Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 108.836 -0.801 . . . . 0.92 108.836 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' GLY . 26.1 Cg_endo -83.41 -73.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.127 1.218 . . . . 1.37 110.18 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.86 -44.9 65.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.845 -0.616 . . . . 4.29 110.879 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -46.56 52.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.192 0.52 . . . . 1.0 111.75 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . -114.66 -178.02 18.92 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 110.431 -1.067 . . . . 0.99 110.431 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -174.12 -47.63 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.946 -0.761 . . . . 3.82 108.946 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.2 10.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.739 -1.119 . . . . 4.47 109.647 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.3 mt -115.73 73.41 4.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 113.232 0.827 . . . . 3.8 113.232 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -87.53 117.17 1.19 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 123.146 2.564 . . . . 3.61 110.986 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -85.45 -77.91 0.28 Allowed 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 118.015 -1.474 . . . . 3.07 111.196 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.1 mt -154.45 -87.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.952 1.358 . . . . 2.62 110.309 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.86 -24.77 13.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.261 -1.791 . . . . 2.28 111.175 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -65.41 -44.01 88.77 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.734 -0.786 . . . . 2.13 109.071 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.48 -41.14 61.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.858 -0.61 . . . . 1.94 111.029 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.46 -41.05 89.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.508 -0.877 . . . . 2.78 110.031 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.5 -42.2 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.235 0.541 . . . . 1.31 110.572 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.67 -46.42 90.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 1.56 111.55 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -32.82 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.319 -0.552 . . . . 1.54 110.987 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.15 -35.66 77.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.1 -0.5 . . . . 2.45 109.874 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -92.73 -10.89 35.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.886 -0.412 . . . . 2.3 109.886 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.11 -178.84 4.61 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.65 -0.871 . . . . 0.7 108.65 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.414 ' O ' ' OXT' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -109.78 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.911 0.386 . . . . 2.51 110.503 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.414 ' OXT' ' O ' ' A' ' 50' ' ' ILE . 96.0 mt . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.088 -0.958 . . . . 2.29 111.449 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_